Notices of Compliance, 2021
2,372 notices issued in 2021, newest first.
| Date | Products | Company | Submission |
|---|---|---|---|
| December 31, 2021 | ENTROPHEN 325 MG CAPLETS; ENTROPHEN 325 MG TABLETS; ENTROPHEN CHEWABLE | Pendopharm Division Of Pharmascience Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 31, 2021 | VOLTAREN EMULGEL; VOLTAREN EMULGEL BACK & MUSCLE PAIN; VOLTAREN EMULGEL JOINT PAIN REGULAR STRENGTH | Glaxosmithkline Consumer Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| December 31, 2021 | ENTROPHEN | Pendopharm Division Of Pharmascience Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 31, 2021 | TARO-TERCONAZOLE | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 31, 2021 | MEZERA | Avir Pharma Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 31, 2021 | VOTRIENT | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 31, 2021 | AZITHROMYCIN FOR INJECTION | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| December 31, 2021 | MOXICLOPRID 55; MOXICLOPRID 10; MOXICLOPRID 100; MOXICLOPRID 18; MOXICLOPRID 20; MOXICLOPRID 9 | Modern Veterinary Therapeutics Llc | Abbreviated New Drug Submission (ANDS) · Other |
| December 30, 2021 | ZYBAN | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 30, 2021 | JAMP-BICALUTAMIDE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 30, 2021 | APO-OXYCODONE CR | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 30, 2021 | SOMAVERT | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| December 30, 2021 | CELEXA | Lundbeck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 30, 2021 | TEPADINA | Adienne Sa | Supplement to a New Drug Submission (SNDS) · Other |
| December 30, 2021 | MINT-TOPIRAMATE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 30, 2021 | XENICAL | Cheplapharm Arzneimittel Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| December 30, 2021 | TREPROSTINIL INJECTION | Dr Reddys Laboratories Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| December 29, 2021 | ERELZI | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 29, 2021 | ELIGARD | Tolmar International Ltd. | New Drug Submission (NDS) · Admin |
| December 29, 2021 | PRO-MIRTAZAPINE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 29, 2021 | RIVA-TENOFOVIR | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 29, 2021 | SILDENAFIL | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 29, 2021 | ATENOLOL | Sanis Health Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| December 24, 2021 | SUVEXX | Aralez Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 24, 2021 | YUFLYMA | Celltrion Healthcare Co Ltd | New Drug Submission (NDS) · Other |
| December 24, 2021 | PMS-TOPIRAMATE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 24, 2021 | ZOLEDRONIC ACID FOR INJECTION | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 24, 2021 | SANDOZ EVEROLIMUS | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 24, 2021 | TEVA-SALBUTAMOL STERINEBS P.F. | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| December 24, 2021 | SANDOZ CIPROFLOXACIN / DEXAMETHASONE | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 24, 2021 | PMS-BUPRENORPHINE-NALOXONE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 24, 2021 | POLIVY | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| December 23, 2021 | TARO-BUPROPION XL | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| December 23, 2021 | ZELDOX | Upjohn Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| December 23, 2021 | ACT OLMESARTAN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 23, 2021 | TEVA-CLOBAZAM | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 23, 2021 | LAPELGA | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 23, 2021 | PERSERIS | Hls Therapeutics Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 23, 2021 | TICLOPIDINE | Apotex Inc. | New Drug Submission (NDS) · Labelling Only |
| December 23, 2021 | TEVA-LORAZEPAM | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| December 23, 2021 | TARO-RISPERIDONE | Sun Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| December 23, 2021 | JEMPERLI | Glaxosmithkline Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| December 23, 2021 | AURO-RITONAVIR | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| December 22, 2021 | PRIMAXIN | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 22, 2021 | PERINDOPRIL ERBUMINE / INDAPAMIDE; PERINDOPRIL ERBUMINE / INDAPAMIDE HD | Sivem Pharmaceuticals Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| December 22, 2021 | SMARTPOWER SINK & SURFACE CLEANER SANITIZER; SURFACE CLEANER SANITIZER RTU | Ecolab Co. | New Drug Submission (NDS) · Other |
| December 22, 2021 | DEPO-PROVERA | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| December 22, 2021 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 22, 2021 | PMS-OXYCODONE CR | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 22, 2021 | HUMATROPE | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 21, 2021 | AMPROLIUM 250 | Bio Agri Mix Lp | Abbreviated New Drug Submission (ANDS) · Other |
| December 21, 2021 | TIVICAY | Viiv Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| December 21, 2021 | IXIFI | Pfizer Canada Ulc | New Drug Submission (NDS) · Other |
| December 21, 2021 | AURO-CANDESARTAN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 21, 2021 | LAMICTAL | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 21, 2021 | LUCENTIS | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 21, 2021 | SIMVASTATIN-10; SIMVASTATIN-20; SIMVASTATIN-40; SIMVASTATIN-5; SIMVASTATIN-80 | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 21, 2021 | VALSARTAN | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| December 21, 2021 | APO-DIVALPROEX | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| December 20, 2021 | ISOVUE 200 INJECTION; ISOVUE 300 INJECTION; ISOVUE 370 INJECTION; ISOVUE MULTIPACK-300; ISOVUE MULTIPACK-370 | Bracco Imaging Canada | Supplement to a New Drug Submission (SNDS) · Other |
| December 20, 2021 | MICRO +5 CONCENTRATE | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 20, 2021 | KETOROLAC TROMETHAMINE INJECTION USP | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| December 17, 2021 | DEXLANSOPRAZOLE | Takeda Canada Incorporated | New Drug Submission (NDS) · Labelling Only |
| December 17, 2021 | CLORAZEPATE | AA Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 17, 2021 | TRIAZOLAM | AA Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 17, 2021 | HEPTOVIR | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 16, 2021 | ALEMBIC-BOSENTAN | Alembic Pharmaceuticals Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| December 16, 2021 | GALAFOLD | Amicus Therapeutics Uk Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| December 16, 2021 | DOVONEX | Leo Pharma Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 16, 2021 | TEVA-MODAFINIL | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| December 16, 2021 | PMS-IRBESARTAN-HCTZ | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 16, 2021 | PERINDOPRIL ERBUMINE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 16, 2021 | CHLORAX | AA Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 16, 2021 | DEXILANT | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| December 16, 2021 | MYCOPHENOLATE MOFETIL FOR INJECTION, USP | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 16, 2021 | IMBRUVICA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 16, 2021 | NIMENRIX | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| December 15, 2021 | OLMESARTAN | Jubilant Generics Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 15, 2021 | SULFATRIM; SULFATRIM DS; SULFATRIM PEDIATRIC | AA Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 15, 2021 | ADACEL | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| December 15, 2021 | SONOVUE | Bracco Imaging Canada | Supplement to a New Drug Submission (SNDS) · Other |
| December 15, 2021 | BORTEZOMIB FOR INJECTION | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 15, 2021 | DUKORAL | Valneva Sweden Ab | Supplement to a New Drug Submission (SNDS) · Other |
| December 15, 2021 | TEVA-BUSPIRONE | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| December 15, 2021 | ERTAPENEM FOR INJECTION | Hikma Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 15, 2021 | AROMASIN | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| December 15, 2021 | APO-CITALOPRAM | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 15, 2021 | TEVA-SUMATRIPTAN; TEVA-SUMATRIPTAN DF | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 15, 2021 | LIBRAX | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 14, 2021 | MIDAZOLAM INJECTION SDZ | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 14, 2021 | TOPOTECAN INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 14, 2021 | BEOVU | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 14, 2021 | FENTORA | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| December 14, 2021 | TEVA-GLATIRAMER ACETATE | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| December 14, 2021 | POSANOL | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 14, 2021 | AURO-ALENDRONATE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 14, 2021 | JAMP LENALIDOMIDE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| December 13, 2021 | APO-ABACAVIR | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 13, 2021 | SANDOZ OLANZAPINE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 13, 2021 | TRINIPATCH 0.2; TRINIPATCH 0.4; TRINIPATCH 0.6 | Paladin Labs Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 13, 2021 | LUTATHERA | Advanced Accelerator Applications Usa, Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 13, 2021 | PMS-QUETIAPINE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 10, 2021 | RUXIENCE | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| December 10, 2021 | TEVA-CINACALCET | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 10, 2021 | ACH-CAPECITABINE | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 10, 2021 | ACT ZOPICLONE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 10, 2021 | TEVA-CLONAZEPAM | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 10, 2021 | PRO-ZOPICLONE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 10, 2021 | ETODOLAC | AA Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| December 10, 2021 | ALENDRONATE | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| December 10, 2021 | IRBESARTAN | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 10, 2021 | TELMISARTAN/HCTZ | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 10, 2021 | JAMP SOLIFENACIN SUCCINATE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| December 10, 2021 | VALSARTAN | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| December 10, 2021 | NRA-ALENDRONATE | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| December 10, 2021 | PDP-AMANTADINE HYDROCHLORIDE CAPSULES; PDP-AMANTADINE HYDROCHLORIDE SYRUP | Pendopharm Division Of Pharmascience Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 10, 2021 | XELJANZ; XELJANZ XR | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| December 10, 2021 | JADENU | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 10, 2021 | EXJADE | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 9, 2021 | TECENTRIQ | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| December 9, 2021 | REPATHA | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 9, 2021 | PMS-CLONAZEPAM | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 9, 2021 | SANDOZ ABIRATERONE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 9, 2021 | ISOPTIN SR | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| December 9, 2021 | TEVA-AMIODARONE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 9, 2021 | FLUOXETINE | Sanis Health Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| December 9, 2021 | NOLVADEX-D | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 8, 2021 | TARO-TICAGRELOR | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 8, 2021 | VORICONAZOLE FOR INJECTION | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 8, 2021 | MYLAN-CILAZAPRIL | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 8, 2021 | DARZALEX; DARZALEX SC | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 8, 2021 | TAFINLAR | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 8, 2021 | TOMUDEX | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| December 8, 2021 | CAMBIA | Aralez Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 7, 2021 | PMS-METOPROLOL-L | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 7, 2021 | PMS-CLOBAZAM | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 7, 2021 | INFANRIX HEXA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 7, 2021 | BOOSTRIX-POLIO | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 7, 2021 | INFANRIX-IPV/HIB | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 7, 2021 | BOOSTRIX | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 7, 2021 | NALCROM | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 7, 2021 | TARO-QUETIAPINE | Sun Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| December 7, 2021 | PERINDOPRIL ERBUMINE/INDAPAMIDE; PERINDOPRIL ERBUMINE/INDAPAMIDE HD; PERINDOPRIL ERBUMINE/INDAPAMIDE LD | Pro Doc Limitee | New Drug Submission (NDS) · Labelling Only |
| December 7, 2021 | METOJECT SUBCUTANEOUS | Medexus Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 7, 2021 | SOTALOL | Apotex Inc. | New Drug Submission (NDS) · Labelling Only |
| December 7, 2021 | NAT-LEVETIRACETAM | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 7, 2021 | JAMP-MEMANTINE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| December 7, 2021 | APRAVET | Huvepharma Eood | Abbreviated New Drug Submission (ANDS) · Other |
| December 6, 2021 | OGIVRI | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| December 6, 2021 | LAMOTRIGINE-100; LAMOTRIGINE-150; LAMOTRIGINE-25 | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 6, 2021 | MAR-CIDOFOVIR | Marcan Pharmaceuticals Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 6, 2021 | ACT OLMESARTAN HCT | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 6, 2021 | FLUVOXAMINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 6, 2021 | STRESNIL | Elanco Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| December 6, 2021 | MED-CYPROTERONE | Generic Medical Partners Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 6, 2021 | TERRAMYCIN-AQUA 800 | Phibro Animal Health Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| December 6, 2021 | ALFACALCIDOL CAPSULES | Strides Pharma Canada Inc | Abbreviated New Drug Submission (ANDS) · Other |
| December 3, 2021 | XARELTO | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 3, 2021 | OLMESARTAN | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 3, 2021 | M-LANSOPRAZOLE | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 3, 2021 | MEKINIST | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 3, 2021 | PMS-CLONAZEPAM-R | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 3, 2021 | PERIOGARD ALCOHOL FREE | Colgate-Palmolive Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 3, 2021 | TARO-ANASTROZOLE | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 3, 2021 | AFINITOR; AFINITOR DISPERZ | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 3, 2021 | AVAMYS | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 3, 2021 | MINT-VENLAFAXINE XR | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| December 2, 2021 | ADMELOG | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 2, 2021 | IRBESARTAN | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 2, 2021 | RIVA-ALENDRONATE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 2, 2021 | CYSTO-CONRAY II | Liebel-Flarsheim Company Llc | New Drug Submission (NDS) · Admin |
| December 2, 2021 | LATISSE | Allergan Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 2, 2021 | IRBESARTAN HCT | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 2, 2021 | APO-NORTRIPTYLINE | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| December 2, 2021 | DOMPERIDONE - 10 | Pro Doc Limitee | New Drug Submission (NDS) · Admin |
| December 2, 2021 | BIO-TELMISARTAN | Biomed Pharma | Abbreviated New Drug Submission (ANDS) · Admin |
| December 2, 2021 | ACCEL-DULOXETINE | Accel Pharma Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| December 2, 2021 | ACCEL-HYOSCINE | Accel Pharma Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 2, 2021 | SANDOZ MONTELUKAST | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 2, 2021 | NITROJECT | Omega Laboratories Limited | Supplement to a New Drug Submission (SNDS) · Other |
| December 2, 2021 | APO-RISEDRONATE DR | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 1, 2021 | LANTUS | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 1, 2021 | OPDIVO | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| December 1, 2021 | APIDRA | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 1, 2021 | LIXIANA | Servier Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 1, 2021 | MINT-ARIPIPRAZOLE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 1, 2021 | LORBRENA | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| December 1, 2021 | SANDOZ MONTELUKAST | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 1, 2021 | M-ESCITALOPRAM | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 30, 2021 | INFLUVAC TETRA | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| November 30, 2021 | AYBINTIO | Samsung Bioepis Co., Ltd | New Drug Submission (NDS) · Other |
| November 30, 2021 | SAPHNELO | Astrazeneca Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| November 30, 2021 | ABRILADA | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| November 30, 2021 | TETRABENAZINE TABLETS | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 30, 2021 | SLYND | Duchesnay Inc. | New Drug Submission (NDS) · Other |
| November 30, 2021 | KEPPRA | Ucb Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 30, 2021 | OPTIRAY 240; OPTIRAY 240 (ULTRAJECT); OPTIRAY 300; OPTIRAY 300 (ULTRAJECT); OPTIRAY 320; OPTIRAY 320 ULTRAJECT; OPTIRAY 350; OPTIRAY 350 ULTRAJECT | Liebel-Flarsheim Company Llc | New Drug Submission (NDS) · Admin |
| November 30, 2021 | TARO-DOMPERIDONE | Sun Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| November 29, 2021 | WINDEX MULTI-SURFACE ANTIBACTERIAL DISINFECTANT 2 | S.C. Johnson and Son Limited | Supplement to a New Drug Submission (SNDS) · Other |
| November 29, 2021 | TPOXX | Siga Technologies, Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| November 29, 2021 | HYDROMORPHONE HYDROCHLORIDE INJECTION, USP | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| November 29, 2021 | TEVA-VALGANCICLOVIR | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 29, 2021 | SEROQUEL | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 29, 2021 | MAVIRET | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| November 29, 2021 | OXALIPLATIN INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| November 29, 2021 | SEPTRA PEDIATRIC SUSPENSION | Aspen Pharmacare Canada Inc. | New Drug Submission (NDS) · Labelling Only |
| November 26, 2021 | IMVAMUNE | Bavarian Nordic As | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 26, 2021 | ENERZAIR BREEZHALER | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 26, 2021 | TRELSTAR | Knight Therapeutics Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 26, 2021 | AMIKACIN SULFATE INJECTION USP | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 26, 2021 | SALOFALK | Aptalis Pharma Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| November 26, 2021 | SALOFALK | Aptalis Pharma Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| November 25, 2021 | FIBRYGA | Octapharma Pharmazeutika Produktionsges M B H | Supplement to a New Drug Submission (SNDS) · Other |
| November 25, 2021 | ALERTEC | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| November 25, 2021 | WINRHO SDF | Saol Therapeutics Research Limited | Supplement to a New Drug Submission (SNDS) · Other |
| November 25, 2021 | TRURAPI | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 25, 2021 | SANDOZ QUETIAPINE XR | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 25, 2021 | CYKLOKAPRON | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| November 25, 2021 | MINT-HYDROXYCHLOROQUINE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 25, 2021 | RIVA-RISEDRONATE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 25, 2021 | MINT-QUETIAPINE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 25, 2021 | PLIAGLIS | Sciences de la Peau CRESCITA Inc. | New Drug Submission (NDS) · Admin |
| November 25, 2021 | NIX DERMAL CREAM | Glaxosmithkline Consumer Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| November 25, 2021 | DIPRIVAN 1% | Aspen Pharmacare Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 25, 2021 | AG-DULOXETINE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 25, 2021 | APO-DESMOPRESSIN | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| November 24, 2021 | LANSOPRAZOLE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 24, 2021 | KUVAN | Biomarin International Limited | Supplement to a New Drug Submission (SNDS) · Other |
| November 24, 2021 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 24, 2021 | MINT-ABACAVIR | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 24, 2021 | ERTAPENEM FOR INJECTION | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 24, 2021 | SHINGRIX | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 24, 2021 | LOSEC | Cheplapharm Arzneimittel Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| November 24, 2021 | RIMADYL | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 24, 2021 | UPTRAVI | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 24, 2021 | IRINOTECAN HYDROCHLORIDE INJECTION | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 23, 2021 | BEOVU | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 23, 2021 | GARDASIL 9 | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 23, 2021 | WEGOVY | Novo Nordisk Canada Inc | New Drug Submission (NDS) · Other |
| November 23, 2021 | TARO-DOCETAXEL | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 23, 2021 | VEKLURY | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 23, 2021 | JANSSEN COVID-19 VACCINE | Janssen Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| November 22, 2021 | BALVERSA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 22, 2021 | TRIUMEQ | Viiv Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| November 22, 2021 | UVADEX | Therakos Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 22, 2021 | OCTREOTIDE ACETATE INJECTION | Generic Medical Partners Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 22, 2021 | APO-MONTELUKAST | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| November 22, 2021 | ONCASPAR | Servier Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 22, 2021 | HYDROMORPHONE HYDROCHLORIDE INJECTION | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 22, 2021 | FETZIMA | Allergan Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 22, 2021 | TEVA-PROGESTERONE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 22, 2021 | PRZ-AMLODIPINE | Pharmaris Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| November 22, 2021 | BELKYRA | Allergan Inc | New Drug Submission (NDS) · Labelling Only |
| November 22, 2021 | MAR-DILTIAZEM CD | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 20, 2021 | AYBINTIO | Samsung Bioepis Co., Ltd | New Drug Submission (NDS) · Other |
| November 19, 2021 | VAXZEVRIA | Astrazeneca Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| November 19, 2021 | LUCENTIS | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 19, 2021 | ENHERTU | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 19, 2021 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 19, 2021 | LUPRON; LUPRON DEPOT | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| November 19, 2021 | PMS-CITALOPRAM | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 19, 2021 | COLD + SINUS DAYTIME; COLD + SINUS NIGHTTIME | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 19, 2021 | PMS-FLUOXETINE | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 19, 2021 | PMS-PAROXETINE | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 19, 2021 | COMIRNATY | Biontech Manufacturing Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| November 18, 2021 | TEVA-LEFLUNOMIDE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 18, 2021 | DOCETAXEL INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 18, 2021 | DEPAKENE | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| November 18, 2021 | CIPROFLOXACIN INJECTION USP | Pfizer Canada Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| November 18, 2021 | M-FINASTERIDE | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| November 18, 2021 | SYNOVEX LA-G | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 17, 2021 | APO-TRAMADOL | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 17, 2021 | M-DULOXETINE | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 17, 2021 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 16, 2021 | ESOMEPRAZOLE | Ethypharm Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 16, 2021 | DAPTOMYCIN FOR INJECTION | Juno Pharmaceuticals Corp. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 16, 2021 | ZYTIGA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 16, 2021 | TEVA-TELMISARTAN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 16, 2021 | CAMCEVI | Accord Healthcare Inc | New Drug Submission (NDS) · Other |
| November 16, 2021 | VAXNEUVANCE | Merck Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| November 16, 2021 | PMS-PAROXETINE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 16, 2021 | SEPTANEST N; SEPTANEST SP | Septodont | Supplement to a New Drug Submission (SNDS) · Other |
| November 16, 2021 | RESTORIL | AA Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 15, 2021 | APO-CLOBETASOL SPRAY | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 15, 2021 | CANDESARTAN | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 15, 2021 | PMS-MIRTAZAPINE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 15, 2021 | JAMP-RISPERIDONE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 15, 2021 | DORZOLAMIDE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| November 15, 2021 | MIDAZOLAM INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 14, 2021 | PRAMIPEXOLE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 12, 2021 | PROVOCHOLINE INHALATION SOLUTION | Methapharm Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 12, 2021 | GLASSIA | Takeda Canada Incorporated | New Drug Submission (NDS) · Other |
| November 12, 2021 | SPIKEVAX | Modernatx, Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 12, 2021 | ATECTURA BREEZHALER | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 12, 2021 | NEXVIAZYME | Sanofi-Aventis Canada Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| November 12, 2021 | COLD + SINUS PLUS | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 12, 2021 | NAT-CETIRIZINE | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 12, 2021 | APO-ALPRAZ; APO-ALPRAZ TS | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 12, 2021 | SANDOZ CAPECITABINE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 12, 2021 | APO-IBUPROFEN | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 12, 2021 | TIZANIDINE | AA Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 12, 2021 | CADUET | Upjohn Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| November 12, 2021 | LIPITOR | Upjohn Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| November 10, 2021 | IPG-ATENOLOL | Marcan Pharmaceuticals Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 10, 2021 | HEMLIBRA | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| November 10, 2021 | HYPERRAB | Grifols Therapeutics Llc | Supplement to a New Drug Submission (SNDS) · Other |
| November 10, 2021 | BICNU | Marcan Pharmaceuticals Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 10, 2021 | M-CLOPIDOGREL | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 10, 2021 | RIVA-ZOPICLONE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 10, 2021 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | Strides Pharma Canada Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| November 10, 2021 | M-DARUNAVIR | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| November 10, 2021 | PMS-TADALAFIL | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 10, 2021 | MINT-QUETIAPINE XR | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| November 10, 2021 | ZOFRAN; ZOFRAN ODT | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 10, 2021 | SALOFALK | Aptalis Pharma Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| November 10, 2021 | ULTRACAINE D-S FORTE INJECTION; ULTRACAINE D-S INJECTION | Hansamed Limited | Supplement to a New Drug Submission (SNDS) · Other |
| November 10, 2021 | PMS-DULOXETINE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 9, 2021 | SANDOZ ENALAPRIL | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 9, 2021 | PMS-AMLODIPINE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 9, 2021 | GEMCITABINE INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 9, 2021 | GEMCITABINE SUN FOR INJECTION | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 9, 2021 | TEVA-5 ASA | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| November 9, 2021 | TARO-ACYCLOVIR | Taro Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| November 9, 2021 | COMIRNATY | Biontech Manufacturing Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| November 9, 2021 | POWERMECTIN | Wecan Sales Ltd | New Drug Submission (NDS) · Admin |
| November 8, 2021 | NYVEPRIA | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| November 8, 2021 | ELOCTATE | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 8, 2021 | ROCURONIUM BROMIDE INJECTION | Strides Pharma Canada Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 8, 2021 | LIDOCAINE HYDROCHLORIDE INJECTION | Laboratoire Aguettant | Abbreviated New Drug Submission (ANDS) · Other |
| November 8, 2021 | ONDANSETRON INJECTION, USP (PRESERVATIVE FREE); ONDANSETRON INJECTION, USP (WITH PRESERVATIVE) | Strides Pharma Canada Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| November 8, 2021 | ACLASTA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 8, 2021 | CANDESARTAN-HCTZ | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 8, 2021 | NABUMETONE | AA Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| November 8, 2021 | APO-KETOCONAZOLE | Apotex Inc. | New Drug Submission (NDS) · Admin |
| November 8, 2021 | NAT-MONTELUKAST | Natco Pharma (Canada) Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| November 5, 2021 | ALPROLIX | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 5, 2021 | ABEVMY | BGP Pharma ULC | New Drug Submission (NDS) · Other |
| November 5, 2021 | ADYNOVATE | Shire Pharma Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| November 5, 2021 | NUCALA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 5, 2021 | FLAGYL | Odan Laboratories Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| November 5, 2021 | PRO-RISPERIDONE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 5, 2021 | BOSULIF | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| November 5, 2021 | PMS-PERINDOPRIL | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 5, 2021 | MAR-MYCOPHENOLATE MOFETIL | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| November 5, 2021 | REVOLADE | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 5, 2021 | SEPTRA INJECTION | Aspen Pharmacare Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 4, 2021 | EMGALITY | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 4, 2021 | BEOVU | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 4, 2021 | GENTAMICIN INJECTION USP | Telip, Llc, A Subsidiary Of Teligent, Inc. | New Drug Submission (NDS) · Labelling Only |
| November 4, 2021 | REDDY-CINACALCET | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 4, 2021 | WELLBUTRIN XL | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 4, 2021 | PDP-LEVETIRACETAM | Pendopharm Division Of Pharmascience Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 4, 2021 | DAPTOMYCIN FOR INJECTION | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 4, 2021 | KYNMOBI | Sunovion Pharmaceuticals Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 4, 2021 | ACYCLOVIR SODIUM INJECTION | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 4, 2021 | DIFLUCAN | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| November 4, 2021 | SANDOZ GEFITINIB | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 4, 2021 | SPRYCEL | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| November 4, 2021 | DORZOLAMIDE-TIMOLOL | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| November 3, 2021 | REBLOZYL | Celgene Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 3, 2021 | TEVA-TAMOXIFEN | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| November 3, 2021 | NAT-BENDAMUSTINE | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 3, 2021 | VENLAFAXINE XR | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 3, 2021 | ZEJULA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 3, 2021 | PRZ-DOMPERIDONE | Pharmaris Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| November 3, 2021 | XTANDI | Astellas Pharma Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 3, 2021 | PEDIAPHARM NAPROXEN SUSPENSION | Medexus Pharmaceuticals Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 2, 2021 | ZOLGENSMA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 2, 2021 | KADCYLA | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| November 2, 2021 | PMS-FLUOXETINE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 2, 2021 | APO-FINGOLIMOD | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 2, 2021 | BIKTARVY | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 1, 2021 | HERCEPTIN | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| November 1, 2021 | TARO-BORTEZOMIB | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 1, 2021 | TARO-ADAPALENE/BENZOYL PEROXIDE FORTE | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 29, 2021 | PADCEV | Seagen Inc. | New Drug Submission (NDS) · Priority-NAS |
| October 29, 2021 | JAMP-SILDENAFIL R | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 29, 2021 | BACLOFEN INJECTION | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 29, 2021 | NAT-RIZATRIPTAN ODT | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 29, 2021 | JAMP PREGABALIN CAPSULES | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| October 29, 2021 | TELMISARTAN | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 29, 2021 | NRA-AMLODIPINE | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 29, 2021 | PMS-METOCLOPRAMIDE ORAL SOLUTION; PMS-METOCLOPRAMIDE TABLETS | Pharmascience Inc. | New Drug Submission (NDS) · Admin |
| October 29, 2021 | GABAPENTIN | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| October 29, 2021 | ZEPOSIA | Celgene Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 29, 2021 | JAMP AMBRISENTAN | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| October 29, 2021 | JARDIANCE | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| October 28, 2021 | OPDIVO | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| October 28, 2021 | IPG-QUETIAPINE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 28, 2021 | JAMP TELMISARTAN | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 28, 2021 | JAMP OLMESARTAN | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| October 28, 2021 | TIZANIDINE | AA Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 27, 2021 | AVSOLA | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 27, 2021 | SUBOXONE | Indivior Uk Limited | Supplement to a New Drug Submission (SNDS) · Other |
| October 27, 2021 | EUTHYROX | Emd Serono A Division Of Emd Inc Canada | Supplement to a New Drug Submission (SNDS) · Other |
| October 27, 2021 | AG-CELECOXIB | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 27, 2021 | SANDOZ LANSOPRAZOLE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 27, 2021 | IBUPROFEN CAPLETS; IBUPROFEN EXTRA STRENGTH CAPLETS | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 27, 2021 | MUSCLE & JOINT | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 27, 2021 | FLUCONAZOLE 150 | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 27, 2021 | ADDERALL XR | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| October 27, 2021 | NRA-CETIRIZINE | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 27, 2021 | MYCOPHENOLATE MOFETIL FOR INJECTION USP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 27, 2021 | SANDOZ AZITHROMYCIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 26, 2021 | NGENLA | Pfizer Canada Ulc | New Drug Submission (NDS) · New Active Substance (NAS) |
| October 26, 2021 | LIBTAYO | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 26, 2021 | NEISVAC-C | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| October 26, 2021 | BIAXIN; BIAXIN BID | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| October 26, 2021 | SANDOZ FESOTERODINE FUMARATE | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 26, 2021 | MINT-ATENOL | Mint Pharmaceuticals Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 25, 2021 | PANHEMATIN | Recordati Rare Diseases Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 25, 2021 | VECTIBIX | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 25, 2021 | SANDOSTATIN | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 25, 2021 | NAT-GEFITINIB | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 25, 2021 | MINT-EMTRICITABINE/TENOFOVIR | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| October 25, 2021 | TEVA-AMPHETAMINE XR | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 25, 2021 | ENSTILAR | Leo Pharma Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 25, 2021 | SHINGRIX | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 22, 2021 | TARO-MYCOPHENOLATE | Sun Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 22, 2021 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 22, 2021 | PMS-ATENOLOL | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 22, 2021 | SANDOZ ABIRATERONE | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 22, 2021 | KETOROLAC TROMETHAMINE INJECTION, USP | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 22, 2021 | JAMP-FLUOXETINE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| October 22, 2021 | STROMECTOL | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 22, 2021 | JUBLIA | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 22, 2021 | PRZ-ATORVASTATIN | Pharmaris Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 22, 2021 | PMS-DESMOPRESSIN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 22, 2021 | BIO-DULOXETINE | Biomed Pharma | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 21, 2021 | BIO-CLOPIDOGREL | Biomed Pharma | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 21, 2021 | INTRAROSA | Endoceutics Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 21, 2021 | VOLTAREN; VOLTAREN SR | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 21, 2021 | VOLTAREN RAPIDE | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 21, 2021 | TRANEXAMIC ACID INJECTION USP | Omega Laboratories Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 21, 2021 | APO-TEMAZEPAM | Apotex Inc. | New Drug Submission (NDS) · Admin |
| October 21, 2021 | CYCLOBENZAPRINE - 10 | Pro Doc Limitee | New Drug Submission (NDS) · Admin |
| October 21, 2021 | QUETIAPINE TABLETS | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 21, 2021 | PMS-VALPROIC ACID; PMS-VALPROIC ACID E.C. | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 21, 2021 | PACLITAXEL INJECTION USP | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 21, 2021 | SANDOZ OLMESARTAN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 20, 2021 | PANTOPRAZOLE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 20, 2021 | MELOXIMED | Bimeda-MTC Animal Health Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 20, 2021 | PLAQUENIL | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 19, 2021 | OZEMPIC | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 19, 2021 | METHOTREXATE INJECTION, USP | Strides Pharma Canada Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| October 19, 2021 | PMS-TENOFOVIR | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 19, 2021 | PMSC-VENLAFAXINE XR | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 19, 2021 | TEVA-TEMOZOLOMIDE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 19, 2021 | TARO-TACROLIMUS | Sun Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| October 19, 2021 | TEVA-TEMOZOLOMIDE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 19, 2021 | BUSPIRONE | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 19, 2021 | BRIDION | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 18, 2021 | TEVA-DULOXETINE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 18, 2021 | CROMOLYN EYE DROPS | Pendopharm Division Of Pharmascience Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 18, 2021 | ALLEGRA 12 HOUR; ALLEGRA 24 HOUR; ALLEGRA HIVES | Sanofi Consumer Health Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 18, 2021 | DARUNAVIR | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| October 18, 2021 | CEPHALEXIN | Sanis Health Inc. | New Drug Submission (NDS) · Labelling Only |
| October 18, 2021 | MINT-ROSUVASTATIN | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| October 15, 2021 | SANDOZ PAZOPANIB | Sandoz Canada Inc. | New Drug Submission (NDS) · Admin |
| October 15, 2021 | PMS-RAMIPRIL-HCTZ | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 15, 2021 | REMICADE | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 15, 2021 | MILRINONE LACTATE INJECTION USP | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 15, 2021 | OLOPATADINE | Sanis Health Inc. | New Drug Submission (NDS) · Admin |
| October 15, 2021 | EPIVAL | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| October 15, 2021 | APO-PREGABALIN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 15, 2021 | PAXIL CR | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 15, 2021 | PAXIL | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 15, 2021 | FLUCONAZOLE-150 | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 15, 2021 | DIARRHEA RELIEF | Vita Health Products Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 15, 2021 | ENTOCORT | Tillotts Pharma Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| October 14, 2021 | INCRELEX | Ipsen Biopharmaceuticals Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 14, 2021 | CLOPIDOGREL | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 14, 2021 | COSENTYX | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 14, 2021 | PMS-ATORVASTATIN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 14, 2021 | FLUDARABINE PHOSPHATE INJECTION, USP | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 14, 2021 | TEVA-TELMISARTAN HCTZ | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 14, 2021 | BUSULFAN FOR INJECTION | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 14, 2021 | IRBESARTAN/HCTZ | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 14, 2021 | FLURAZEPAM | AA Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 14, 2021 | COCCIAID | Aurora Pharmaceutical, Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 14, 2021 | OPSYNVI | Janssen Inc. | New Drug Submission (NDS) · Other |
| October 13, 2021 | PANTOPRAZOLE-20; PANTOPRAZOLE-40 | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 13, 2021 | ADTRALZA | Leo Pharma Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| October 13, 2021 | OPDIVO | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| October 13, 2021 | IMATINIB | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| October 13, 2021 | OZEMPIC | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 13, 2021 | SYNTHROID | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| October 13, 2021 | FERRIPROX | Chiesi Canada Corp. | Supplement to a New Drug Submission (SNDS) · Other |
| October 13, 2021 | AG-BISOPROLOL | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 13, 2021 | PAROXETINE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 12, 2021 | GIVLAARI | Alnylam Netherlands B.V. | Supplement to a New Drug Submission (SNDS) · Other |
| October 12, 2021 | ADACEL-POLIO | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| October 12, 2021 | ORENCIA | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| October 12, 2021 | KIRSTY | BGP Pharma ULC | New Drug Submission (NDS) · Other |
| October 12, 2021 | ACH-OLMESARTAN | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 12, 2021 | ROZLYTREK | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| October 12, 2021 | CABOMETYX | Ipsen Biopharmaceuticals Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 8, 2021 | NYPOZI | Tanvex Biopharma Usa, Inc. | New Drug Submission (NDS) · Other |
| October 8, 2021 | SOMAVERT | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| October 8, 2021 | SAXENDA | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 8, 2021 | LEMTRADA | Sanofi Genzyme, A Division Of Sanofi-Aventis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 8, 2021 | VFEND | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| October 8, 2021 | RIVA-FINASTERIDE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 8, 2021 | M-ATORVASTATIN | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 8, 2021 | SANDOZ QUETIAPINE XRT | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 8, 2021 | MICONAZOLE NITRATE VAGINAL CREAM USP, 2% | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 8, 2021 | ALTRENO | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 8, 2021 | MEZERA | Avir Pharma Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 8, 2021 | VOSEVI | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 8, 2021 | ACH-OLMESARTAN HCTZ | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 8, 2021 | MAVENCLAD | Emd Serono A Division Of Emd Inc Canada | Supplement to a New Drug Submission (SNDS) · Other |
| October 8, 2021 | TECFIDERA | Biogen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 8, 2021 | NRA-TADALAFIL | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 7, 2021 | APO-AMOXI | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 7, 2021 | MONTELUKAST | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 7, 2021 | PMS-RISEDRONATE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 7, 2021 | ACTIVASE RT-PA | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| October 7, 2021 | MYRBETRIQ | Astellas Pharma Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 7, 2021 | JAMP METFORMIN | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 6, 2021 | PERJETA; PERJETA - HERCEPTIN COMBO PACK | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| October 6, 2021 | RINVOQ | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| October 6, 2021 | TELMISARTAN-HCTZ | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 6, 2021 | ELTROXIN | Aspen Pharmacare Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 6, 2021 | APO-IRBESARTAN/HCTZ | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 6, 2021 | VORICONAZOLE FOR INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 6, 2021 | EPCLUSA | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 5, 2021 | ZOPICLONE | Sivem Pharmaceuticals Ulc | Supplement to a New Drug Submission (SNDS) · Admin |
| October 5, 2021 | DONEPEZIL | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Other |
| October 5, 2021 | TRAZODONE-100; TRAZODONE-150 D; TRAZODONE-50 | Pro Doc Limitee | Supplement to a New Drug Submission (SNDS) · Admin |
| October 5, 2021 | AG-ONDANSETRON | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 5, 2021 | DIFLUCAN ONE | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| October 5, 2021 | PMS-FINGOLIMOD | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 5, 2021 | UPTRAVI | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 5, 2021 | IMDUR | Juno Pharmaceuticals Corp. | Supplement to a New Drug Submission (SNDS) · Other |
| October 4, 2021 | RIXIMYO | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 4, 2021 | KETAMINE HYDROCHLORIDE INJECTION USP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 4, 2021 | CELECOXIB | Alembic Pharmaceuticals Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 4, 2021 | IRINOTECAN HYDROCHLORIDE INJECTION, USP | Generic Medical Partners Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 4, 2021 | PLENDIL | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 4, 2021 | SANDOZ DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 4, 2021 | SANDOZ DIMETHYL FUMARATE | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 4, 2021 | ACH-DIMETHYL FUMARATE | Accord Healthcare Inc | Abbreviated New Drug Submission (ANDS) · Other |
| October 4, 2021 | PMS-DIMETHYL FUMARATE | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 4, 2021 | APO-DIMETHYL FUMARATE | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 4, 2021 | TEVA-DIMETHYL FUMARATE | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| October 4, 2021 | GLN-DIMETHYL FUMARATE | Glenmark Pharmaceuticals Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 4, 2021 | JAMP DIMETHYL FUMARATE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| October 4, 2021 | MAR-DIMETHYL FUMARATE | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 4, 2021 | PMS-DIMETHYL FUMARATE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 4, 2021 | APO-LAMOTRIGINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 4, 2021 | APO-DIMETHYL FUMARATE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 4, 2021 | TEVA-DIMETHYL FUMARATE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 4, 2021 | MAR-DIMETHYL FUMARATE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 4, 2021 | METHOTREXATE SUBCUTANEOUS | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 4, 2021 | GLN-DIMETHYL FUMARATE | Glenmark Pharmaceuticals Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 1, 2021 | PMS-ONDANSETRON | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 1, 2021 | SODIUM NITROPRUSSIDE FOR INJECTION | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 1, 2021 | PMS-ZOPICLONE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 1, 2021 | TRINIPATCH 0.2; TRINIPATCH 0.4; TRINIPATCH 0.6 | Paladin Labs Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 1, 2021 | INLYTA | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| October 1, 2021 | AZITHROMYCIN FOR INJECTION, USP | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 1, 2021 | TARO-ATORVASTATIN | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 1, 2021 | RUKOBIA | Viiv Healthcare Ulc | New Drug Submission (NDS) · Priority-NAS |
| October 1, 2021 | SIMVASTATIN | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Other |
| September 29, 2021 | ZOLOFT | Upjohn Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| September 29, 2021 | BLES | Bles Biochemicals Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 29, 2021 | GRASTOFIL | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 29, 2021 | JAMP-DULOXETINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 29, 2021 | THEO ER | AA Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 29, 2021 | ZEPZELCA | Jazz Pharmaceuticals Ireland Limited | New Drug Submission (NDS) · New Active Substance (NAS) |
| September 29, 2021 | PRO-OTIC HC | Can-Vet Animal Health Supplies Ltd. | New Drug Submission (NDS) · Admin |
| September 29, 2021 | APO-RISPERIDONE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 28, 2021 | NAT-LENALIDOMIDE | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 28, 2021 | OLANZAPINE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 28, 2021 | MINT-TRAMADOL/ACET | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 28, 2021 | CUVITRU | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| September 28, 2021 | LYNPARZA | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 28, 2021 | DIFFERIN; DIFFERIN XP | Galderma Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 28, 2021 | REPLAGAL | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| September 28, 2021 | TEVA-OXYBUTYNIN | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 27, 2021 | VENLAFAXINE XR | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 27, 2021 | IPG-ATENOLOL | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 27, 2021 | TRUSELTIQ | Qed Therapeutics, Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| September 27, 2021 | ENALAPRIL | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| September 24, 2021 | ACCEL-SEVELAMER | Accel Pharma Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 24, 2021 | CONTRAVE | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 24, 2021 | BOSULIF | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| September 24, 2021 | TRODELVY | Gilead Sciences Canada Inc | New Drug Submission (NDS) · Priority-NAS |
| September 24, 2021 | FLULAVAL TETRA | Id Biomedical Corporation Of Quebec | Supplement to a New Drug Submission (SNDS) · Other |
| September 24, 2021 | PMS-SODIUM CROMOGLYCATE | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 24, 2021 | BRILINTA | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 24, 2021 | FLUVIRAL | Id Biomedical Corporation Of Quebec | Supplement to a New Drug Submission (SNDS) · Other |
| September 24, 2021 | PRO-GABAPENTIN | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 24, 2021 | AURO-TELMISARTAN HCTZ | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 24, 2021 | APO-FLUCONAZOLE-150 | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 24, 2021 | MUSCLE AND BACK PAIN PLATINUM RELIEF | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 24, 2021 | DIARRHEA RELIEF FAST DISSOLVE | Juno Otc Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 24, 2021 | COLD + SINUS | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 24, 2021 | MICODERM | Can-Vet Animal Health Supplies Ltd. | New Drug Submission (NDS) · Admin |
| September 24, 2021 | OLANZAPINE ODT | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| September 23, 2021 | BAMBEVI | Apotex Inc. | New Drug Submission (NDS) · Other |
| September 23, 2021 | VIMOVO | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 23, 2021 | MEZAVANT | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| September 23, 2021 | DULOXETINE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 23, 2021 | RIVA-RISPERIDONE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 23, 2021 | MINT-PREGABALIN | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| September 23, 2021 | RIVA-ATORVASTATIN | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 23, 2021 | NRA-LETROZOLE | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| September 23, 2021 | MEGESTROL | AA Pharma Inc. | New Drug Submission (NDS) · Admin |
| September 23, 2021 | APO-TERAZOSIN | Apotex Inc. | New Drug Submission (NDS) · Admin |
| September 23, 2021 | ESOMEPRAZOLE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| September 23, 2021 | MOXIFLOXACIN | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| September 23, 2021 | DUAKLIR GENUAIR | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 22, 2021 | PMS-LORAZEPAM | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 22, 2021 | ULTOMIRIS | Alexion Pharma Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| September 22, 2021 | KINERET | Swedish Orphan Biovitrum Ab (Publ) | Supplement to a New Drug Submission (SNDS) · Other |
| September 22, 2021 | PRO-GABAPENTIN | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 22, 2021 | INFLUVAC TETRA | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| September 22, 2021 | KYLEENA | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 22, 2021 | SANDOZ IRBESARTAN HCT | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 22, 2021 | SANDOZ PANTOPRAZOLE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 22, 2021 | OBIZUR | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| September 22, 2021 | KIVEXA | Viiv Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| September 21, 2021 | MAR-KETOROLAC | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 21, 2021 | IMFINZI | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 21, 2021 | AURO-QUINAPRIL HCTZ | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| September 21, 2021 | AURO-VORICONAZOLE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 21, 2021 | JAMP TELMISARTAN-HCT | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 21, 2021 | AG-QUETIAPINE XR | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| September 21, 2021 | NAT-ESCITALOPRAM | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 21, 2021 | SANDOZ ATORVASTATIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 21, 2021 | ZOLEDRONIC ACID INJECTION | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 20, 2021 | FONDAPARINUX SODIUM INJECTION | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 20, 2021 | JAMP LINEZOLID | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| September 20, 2021 | ENTOCORT | Tillotts Pharma Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| September 17, 2021 | PRO-RAMIPRIL-1.25; PRO-RAMIPRIL-10; PRO-RAMIPRIL-2.5; PRO-RAMIPRIL-5 | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 17, 2021 | TREMFYA; TREMFYA ONE-PRESS | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 17, 2021 | TECENTRIQ | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 17, 2021 | AG-ESCITALOPRAM | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 17, 2021 | TUDORZA GENUAIR | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 17, 2021 | FINASTERIDE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 17, 2021 | FINASTERIDE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 17, 2021 | RIVA-ROSUVASTATIN | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 17, 2021 | FLAGYSTATIN | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 17, 2021 | FLAGYL | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 17, 2021 | MINT-RISPERIDON | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| September 17, 2021 | ORCIPRENALINE | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| September 17, 2021 | MONOFERRIC | Pharmacosmos A | Supplement to a New Drug Submission (SNDS) · Other |
| September 17, 2021 | PEMAZYRE | Incyte Corporation | New Drug Submission (NDS) · New Active Substance (NAS) |
| September 16, 2021 | COMIRNATY | Biontech Manufacturing Gmbh | New Drug Submission (NDS) · New Active Substance (NAS) |
| September 16, 2021 | SPIKEVAX | Modernatx, Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| September 16, 2021 | IMITREX; IMITREX DF; IMITREX NASAL SPRAY | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 16, 2021 | CLARITHROMYCIN | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 16, 2021 | PMS-NIZATIDINE | Pharmascience Inc. | New Drug Submission (NDS) · Admin |
| September 16, 2021 | PMSC-METFORMIN | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| September 16, 2021 | VAL-ZOLEDRONIC ACID | Bausch Health, Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| September 16, 2021 | ESCITALOPRAM TABLETS | Strides Pharma Canada Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| September 16, 2021 | BUPROPION HCL XL | Bausch Health, Canada Inc. | New Drug Submission (NDS) · Admin |
| September 16, 2021 | NEXIUM | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 16, 2021 | ACH-MYCOPHENOLATE | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| September 16, 2021 | PREVACID; PREVACID FASTAB | Takeda Pharmaceuticals America Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 16, 2021 | DEXILANT | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Labelling Only |
| September 16, 2021 | TENOXICAM | Apotex Inc. | New Drug Submission (NDS) · Labelling Only |
| September 16, 2021 | VARDENAFIL | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| September 15, 2021 | DOVATO | Viiv Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| September 15, 2021 | RIVA-ESCITALOPRAM | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 14, 2021 | YERVOY | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| September 14, 2021 | IDARUBICIN | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Admin |
| September 14, 2021 | LYUMJEV | Eli Lilly Canada Inc | New Drug Submission (NDS) · Other |
| September 14, 2021 | NUCALA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 14, 2021 | BIO-AMLODIPINE | Biomed Pharma | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 14, 2021 | TARO-CARBAMAZEPINE; TARO-CARBAMAZEPINE CHEWABLE TABLETS | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 14, 2021 | TEVA-PREGABALIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 13, 2021 | ACH-LEVETIRACETAM | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 13, 2021 | SANDOZ OLANZAPINE ODT | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 13, 2021 | SARCLISA | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 13, 2021 | TEVA-FLUVASTATIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 13, 2021 | MINT-PERINDOPRIL | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 10, 2021 | HYRIMOZ | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 10, 2021 | FLUZONE HIGH-DOSE QUADRIVALENT; FLUZONE QUADRIVALENT | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 10, 2021 | AMLODIPINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 10, 2021 | PMS-COLCHICINE ER | Pharmascience Inc. | New Drug Submission (NDS) · Admin |
| September 10, 2021 | CORTIPRO SPRAY | Can-Vet Animal Health Supplies Ltd. | New Drug Submission (NDS) · Admin |
| September 10, 2021 | INREBIC | Celgene Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 10, 2021 | PRO-CIPROFLOXACIN | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 10, 2021 | M-ESOMEPRAZOLE | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| September 10, 2021 | LUMAKRAS | Amgen Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| September 10, 2021 | VALCYTE | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 9, 2021 | EYLEA | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 9, 2021 | STELARA; STELARA I.V. | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 9, 2021 | FLULAVAL TETRA | Id Biomedical Corporation Of Quebec | Supplement to a New Drug Submission (SNDS) · Other |
| September 9, 2021 | FLUAD; FLUAD PEDIATRIC | Seqirus Uk Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 9, 2021 | BENZOYLPRO-3 | Can-Vet Animal Health Supplies Ltd. | New Drug Submission (NDS) · Admin |
| September 9, 2021 | TEVA-DILTIAZEM HCL ER | Bausch Health, Canada Inc. | New Drug Submission (NDS) · Admin |
| September 9, 2021 | ACT TERBINAFINE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 9, 2021 | SANDOZ AMLODIPINE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 9, 2021 | AURO-OLMESARTAN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 8, 2021 | JAMP TRETINOIN | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| September 8, 2021 | HYPERTET | Grifols Therapeutics Llc | Supplement to a New Drug Submission (SNDS) · Other |
| September 8, 2021 | HYPERHEP B | Grifols Therapeutics Llc | Supplement to a New Drug Submission (SNDS) · Other |
| September 8, 2021 | DESIPRAMINE | Apotex Inc. | New Drug Submission (NDS) · Labelling Only |
| September 8, 2021 | TARO-CLOBETASOL SPRAY | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 8, 2021 | REBLOZYL | Celgene Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 8, 2021 | XOLAIR | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 8, 2021 | KANUMA | Alexion Pharma Gmbh | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 8, 2021 | NALOXONE HYDROCHLORIDE INJECTION USP | Telip, Llc, A Subsidiary Of Teligent, Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| September 8, 2021 | FUROSEMIDE INJECTION USP | Telip, Llc, A Subsidiary Of Teligent, Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| September 8, 2021 | HALOETTE | Searchlight Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| September 7, 2021 | FLUMIST QUADRIVALENT | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 7, 2021 | LOVENOX; LOVENOX HP | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 7, 2021 | FLUCELVAX QUAD | Seqirus Uk Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 7, 2021 | NAT-ABIRATERONE | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 7, 2021 | SANDOZ LOSARTAN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 3, 2021 | JAMP-AMLODIPINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 3, 2021 | OCTREOTIDE FOR INJECTABLE SUSPENSION | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 3, 2021 | APO-GABAPENTIN TABLETS | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| September 3, 2021 | ZYLOPRIM | AA Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 3, 2021 | ORKAMBI | Vertex Pharmaceuticals (Canada) Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| September 2, 2021 | BIPHENTIN | Elvium Life Sciences | Supplement to a New Drug Submission (SNDS) · Other |
| September 2, 2021 | CLONAPAM | Bausch Health, Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 2, 2021 | FENTANYL CITRATE INJECTION USP | Telip, Llc, A Subsidiary Of Teligent, Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| September 2, 2021 | AURO-OLMESARTAN HCTZ | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 2, 2021 | MINT-IMATINIB | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 2, 2021 | VELPHORO | Vifor Fresenius Medical Care Renal Pharma Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| September 2, 2021 | CLARITHROMYCIN | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| September 2, 2021 | APO-ACYCLOVIR | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| September 2, 2021 | AMLODIPINE TABLETS | Strides Pharma Canada Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| September 2, 2021 | LABETALOL HYDROCHLORIDE INJECTION, USP | Strides Pharma Canada Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| September 2, 2021 | CAPECITABINE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| September 2, 2021 | ALFUZOSIN | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| September 2, 2021 | XOFLUZA | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 2, 2021 | SPRAVATO | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 2, 2021 | RIFEN | Richter Pharma Ag | Abbreviated New Drug Submission (ANDS) · Other |
| September 1, 2021 | ERTAPENEM FOR INJECTION | Juno Pharmaceuticals Corp. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 1, 2021 | NATESTO | Acerus Pharmaceuticals Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| September 1, 2021 | TREANDA | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 1, 2021 | ACETYLCYSTEINE SOLUTION USP | Telip, Llc, A Subsidiary Of Teligent, Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| September 1, 2021 | GEMCITABINE FOR INJECTION | Telip, Llc, A Subsidiary Of Teligent, Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| September 1, 2021 | SANDOZ DARUNAVIR | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| September 1, 2021 | JAMP ALENDRONATE/VITAMIN D3 | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| September 1, 2021 | TRUE NORTH IVERMECTIN | Can-Vet Animal Health Supplies Ltd. | New Drug Submission (NDS) · Admin |
| September 1, 2021 | SYNCAINE | Syndel Canada | Supplement to a New Drug Submission (SNDS) · Admin |
| September 1, 2021 | APO-LENALIDOMIDE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 1, 2021 | APO-LENALIDOMIDE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 1, 2021 | LENALIDOMIDE | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 1, 2021 | SANDOZ LENALIDOMIDE | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| September 1, 2021 | NAT-LENALIDOMIDE | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 1, 2021 | REDDY-LENALIDOMIDE | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| September 1, 2021 | TARO-LENALIDOMIDE | Taro Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| September 1, 2021 | APO-LENALIDOMIDE | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| September 1, 2021 | LENALIDOMIDE | Natco Pharma (Canada) Inc | Abbreviated New Drug Submission (ANDS) · Other |
| September 1, 2021 | REDDY-LENALIDOMIDE | Dr Reddys Laboratories Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| September 1, 2021 | NAT-LENALIDOMIDE | Natco Pharma (Canada) Inc | Abbreviated New Drug Submission (ANDS) · Other |
| September 1, 2021 | REDDY-LENALIDOMIDE | Dr Reddys Laboratories Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| August 31, 2021 | PERINDOPRIL ERBUMINE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 31, 2021 | IRBESARTAN-HCTZ | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 31, 2021 | M-METRONIDAZOLE | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 31, 2021 | QUETIAPINE XR | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| August 31, 2021 | UVADEX | Therakos Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 30, 2021 | IPG-BOSENTAN | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 30, 2021 | M-BETAHISTINE | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 30, 2021 | VORICONAZOLE FOR INJECTION | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 30, 2021 | PERINDOPRIL/INDAPAMIDE | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 30, 2021 | TEVA-DOXYCYCLINE | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| August 30, 2021 | DIAZEPAM INJECTION USP | Telip, Llc, A Subsidiary Of Teligent, Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| August 30, 2021 | IPG-CLOPIDOGREL | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 29, 2021 | OLMESARTAN | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 29, 2021 | PRO-MIRTAZAPINE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 29, 2021 | ATORVASTATIN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 29, 2021 | MINT-PANTOPRAZOLE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 27, 2021 | IRBESARTAN | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 27, 2021 | MONTELUKAST | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 27, 2021 | JAMP-ESCITALOPRAM | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 27, 2021 | PANTOPRAZOLE TABLETS | Strides Pharma Canada Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| August 27, 2021 | M-AMLODIPINE | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 27, 2021 | VALACYCLOVIR | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 27, 2021 | ZOPICLONE TABLETS | Strides Pharma Canada Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| August 27, 2021 | PREGABALIN | Alembic Pharmaceuticals Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 27, 2021 | ONDANSETRON INJECTION USP; ONDANSETRON INJECTION USP (PRESERVATIVE FREE) | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 27, 2021 | PMS-DICLOFENAC | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 27, 2021 | TYGACIL | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| August 27, 2021 | SANDOZ RISEDRONATE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 27, 2021 | ISOVUE 200 INJECTION; ISOVUE 300 INJECTION; ISOVUE 370 INJECTION; ISOVUE MULTIPACK 300; ISOVUE MULTIPACK 370 | Bracco Imaging Canada | Supplement to a New Drug Submission (SNDS) · Other |
| August 27, 2021 | RYTHMOL | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| August 27, 2021 | TEVA-CYCLOBENZAPRINE | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| August 27, 2021 | MINT-BISOPROLOL | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 26, 2021 | DORZOLAMIDE EYE DROPS BP | Teligent Canada Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 26, 2021 | PANTOPRAZOLE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 26, 2021 | PANTOPRAZOLE T | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 26, 2021 | BIO-PANTOPRAZOLE | Biomed Pharma | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 26, 2021 | PANTOPRAZOLE T | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| August 26, 2021 | GLUCOPHAGE | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 26, 2021 | MINT-ATENOL | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 26, 2021 | CRYSVITA | Kyowa Kirin, Inc. | Supplement to a New Drug Submission (SNDS) · Priority |
| August 26, 2021 | APO-PERINDOPRIL TABLETS | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 26, 2021 | REDDY-CLOBETASOL SHAMPOO | Dr. Reddy's Laboratories Canada Inc. | New Drug Submission (NDS) · Admin |
| August 26, 2021 | PMS-ONDANSETRON ODT | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 26, 2021 | SANDOZ LOSARTAN HCT; SANDOZ LOSARTAN HCT DS | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 26, 2021 | XELJANZ; XELJANZ XR | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| August 26, 2021 | HYDROXYCHLOROQUINE | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 26, 2021 | ACETAMINOPHEN INJECTION | Baxter Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| August 25, 2021 | STRENSIQ | Alexion Pharma Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| August 25, 2021 | M-PANTOPRAZOLE | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 25, 2021 | VOTRIENT | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 25, 2021 | SANDOZ SOLIFENACIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| August 25, 2021 | TEVA-GLYBURIDE | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| August 25, 2021 | SANDOZ CANDESARTAN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 25, 2021 | VASCEPA | Hls Therapeutics Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 25, 2021 | KALYDECO | Vertex Pharmaceuticals (Canada) Incorporated | Supplement to a New Drug Submission (SNDS) · Priority |
| August 24, 2021 | MAR-DULOXETINE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 24, 2021 | EXTAVIA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 23, 2021 | DIARRHEA RELIEF FAST DISSOLVE | Juno Otc Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 23, 2021 | NIMENRIX | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| August 23, 2021 | JULUCA | Viiv Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| August 23, 2021 | ADVIL PLUS ACETAMINOPHEN | Glaxosmithkline Consumer Healthcare Ulc | New Drug Submission (NDS) · Other |
| August 23, 2021 | ONDANSETRON ODT | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 23, 2021 | TEVA-ALPRAZOLAM | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 23, 2021 | EPIVAL | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| August 23, 2021 | MYINFLA | Pendopharm Division Of Pharmascience Inc | New Drug Submission (NDS) · Priority |
| August 23, 2021 | JAMP EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| August 20, 2021 | INDAYO | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 20, 2021 | TARO-TELMISARTAN HCTZ | Sun Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| August 20, 2021 | APO-PERINDOPRIL-INDAPAMIDE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 20, 2021 | MOVIPREP | Aralez Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 19, 2021 | MINJUVI | Incyte Corporation | New Drug Submission (NDS) · New Active Substance (NAS) |
| August 19, 2021 | VYEPTI | Lundbeck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 19, 2021 | BEXSERO | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 19, 2021 | SKYRIZI | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| August 19, 2021 | SANDOZ-CARBAMAZEPINE CR | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 19, 2021 | SANDOZ CLOBETASOL | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 19, 2021 | OXALIPLATIN INJECTION, USP | Fresenius Kabi Canada Ltd | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| August 19, 2021 | ALTREN SOLUTION 0.22% | Aurora Pharmaceutical, Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| August 18, 2021 | BEOVU | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 18, 2021 | APO-DULOXETINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 18, 2021 | BIO-MONTELUKAST | Biomed Pharma | Abbreviated New Drug Submission (ANDS) · Admin |
| August 18, 2021 | AG-ALLOPURINOL | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 18, 2021 | RIVA-LANSOPRAZOLE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 18, 2021 | JAMP-ALLOPURINOL | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 18, 2021 | PANTOPRAZOLE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 18, 2021 | METOPROLOL; METOPROLOL SR; METOPROLOL-L | Pro Doc Limitee | Supplement to a New Drug Submission (SNDS) · Admin |
| August 18, 2021 | ONDANSETRON ODT | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| August 18, 2021 | TRANEXAMIC ACID | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| August 18, 2021 | MOMETASONE | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 18, 2021 | BICALUTAMIDE | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 18, 2021 | SANDOZ CANDESARTAN PLUS | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 18, 2021 | TYBOST | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 18, 2021 | NIDAGEL | Bausch Health, Canada Inc. | New Drug Submission (NDS) · Labelling Only |
| August 18, 2021 | PRAMIPEXOLE | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| August 18, 2021 | DIASTAT | Bausch Health, Canada Inc. | New Drug Submission (NDS) · Labelling Only |
| August 17, 2021 | DUPIXENT | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 17, 2021 | METRONIDAZOLE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| August 17, 2021 | RIVAROXABAN | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| August 17, 2021 | AURO-DULOXETINE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 17, 2021 | AA-FENO-SUPER | AA Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 17, 2021 | APO-METFORMIN | Apotex Inc. | New Drug Submission (NDS) · Admin |
| August 17, 2021 | CLINDAMYCIN | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 17, 2021 | TEVA-ATENOLOL | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| August 17, 2021 | PMS-RISPERIDONE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 16, 2021 | EPREX | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 16, 2021 | PACLITAXEL INJECTION, USP | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 13, 2021 | OCTREOSCAN | Curium Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 13, 2021 | LIBTAYO | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 13, 2021 | ZIEXTENZO | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 13, 2021 | PROTOPIC | Leo Pharma Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 13, 2021 | ATACAND PLUS | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 13, 2021 | INQOVI | Otsuka Pharmaceutical Co Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| August 13, 2021 | MEROPENEM FOR INJECTION, USP | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 13, 2021 | TRANEXAMIC ACID INJECTION | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 13, 2021 | AURO-ATORVASTATIN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 13, 2021 | APO-IRBESARTAN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 13, 2021 | APO-VALPROIC ACID; APO-VALPROIC ACID ORAL SOLUTION | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 12, 2021 | JAMP ALPRAZOLAM | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 12, 2021 | LEVEMIR | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 12, 2021 | ZESTORETIC | Searchlight Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 12, 2021 | MOGADON | AA Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 12, 2021 | NOVORAPID | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 12, 2021 | VEKLURY | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 12, 2021 | NOVOMIX 30 | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 12, 2021 | NOVOLIN® GE | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 12, 2021 | APO-DIPYRIDAMOLE; APO-DIPYRIDAMOLE-SC | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 12, 2021 | FORTEO | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 12, 2021 | TARO-MEDROXYPROGESTERONE INJECTION | Taro Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| August 11, 2021 | MAR-ZOPICLONE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 11, 2021 | DORZOLAMIDE AND TIMOLOL EYE DROPS BP | Teligent Canada Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 11, 2021 | MAR-PANTOPRAZOLE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 11, 2021 | TEMAZEPAM | AA Pharma Inc. | New Drug Submission (NDS) · Admin |
| August 11, 2021 | OMNITROPE | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 11, 2021 | MINT-BUSPIRONE | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| August 11, 2021 | BIO-ROSUVASTATIN | Biomed Pharma | Abbreviated New Drug Submission (ANDS) · Admin |
| August 11, 2021 | RIVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 11, 2021 | REDDY-DASATINIB | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 11, 2021 | HYDREA | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| August 11, 2021 | APO-PREGABALIN CAPSULES | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| August 11, 2021 | APO-HYDROXYQUINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 11, 2021 | BLEXTEN | Aralez Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 10, 2021 | MICATIN POWDER SPRAY - UNSCENTED 2% | WellSpring Pharmaceutical Canada Corp. | Supplement to a New Drug Submission (SNDS) · Other |
| August 10, 2021 | BETASERON | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 10, 2021 | ALLERGY REMEDY | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 10, 2021 | TARO-DULOXETINE | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 10, 2021 | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USP | Juno Pharmaceuticals Corp. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 10, 2021 | AZITHROMYCIN FOR INJECTION, USP | Strides Pharma Canada Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| August 10, 2021 | LOXAPINE | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| August 10, 2021 | ORILISSA | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| August 10, 2021 | NAT-TENOFOVIR | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 10, 2021 | FORXIGA | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Priority |
| August 10, 2021 | IBUPROFEN CAPLETS 200 MG; IBUPROFEN TABLETS 200 MG | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 10, 2021 | IBUPROFEN CAPLETS; IBUPROFEN EXTRA STRENGTH CAPLETS; IBUPROFEN TABLETS | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 9, 2021 | MAR-ONDANSETRON | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 9, 2021 | BACLOFEN | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 9, 2021 | GENVOYA | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 9, 2021 | MINT-ZOPICLONE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 9, 2021 | ONIVYDE | Servier Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 9, 2021 | ATRIANCE | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 6, 2021 | MAR-AMLODIPINE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 6, 2021 | MYCOPHENOLIC ACID | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| August 6, 2021 | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | Strides Pharma Canada Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| August 6, 2021 | AURO-PANTOPRAZOLE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 6, 2021 | ALLERGY RELIEF | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 6, 2021 | 24 HOUR ALLERGY REMEDY | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 6, 2021 | ESBRIET | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| August 6, 2021 | NUCYNTA IR | Endo Ventures Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| August 5, 2021 | VIMPAT | Ucb Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 5, 2021 | TRINTELLIX | Lundbeck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 5, 2021 | JAMP BISOPROLOL | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| August 5, 2021 | ZEULIDE DEPOT | Verity Pharmaceuticals Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 5, 2021 | INFANRIX-HEXA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 5, 2021 | BOOSTRIX-POLIO | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 5, 2021 | BOOSTRIX | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 5, 2021 | JAMP SPIRONOLACTONE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| August 5, 2021 | DAPTOMYCIN FOR INJECTION RF | Baxter Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| August 4, 2021 | HADLIMA; HADLIMA PUSHTOUCH | Samsung Bioepis Co., Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| August 4, 2021 | KANJINTI | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 4, 2021 | NPLATE | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 4, 2021 | KISQALI | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 4, 2021 | M-CELECOXIB | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| August 4, 2021 | SANDOZ EZETIMIBE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 4, 2021 | JAMP TRAMADOL HCL | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| August 3, 2021 | LEVOTHYROXINE SODIUM FOR INJECTION; LEVOTHYROXINE SODIUM INJECTION | Fresenius Kabi Canada Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| July 30, 2021 | MAR-CELECOXIB | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 30, 2021 | ZESTRIL | Searchlight Pharma Inc. | New Drug Submission (NDS) · Admin |
| July 30, 2021 | TENORMIN | Searchlight Pharma Inc. | New Drug Submission (NDS) · Admin |
| July 30, 2021 | PMS-DIGOXIN | Pharmascience Inc. | New Drug Submission (NDS) · Admin |
| July 30, 2021 | SANDOZ MYCOPHENOLATE MOFETIL | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 30, 2021 | TEVA-VORICONAZOLE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 30, 2021 | PMS-SILDENAFIL R | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 30, 2021 | SANDOZ TELMISARTAN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 30, 2021 | MENJUGATE LIQUID | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 30, 2021 | MAR-ENALAPRIL | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 30, 2021 | MINT-IRBESARTAN | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 30, 2021 | NUCYNTA EXTENDED-RELEASE | Endo Ventures Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| July 30, 2021 | DEXEDRINE TABLETS (5 MG) | Paladin Labs Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 30, 2021 | BIVALIRUDIN FOR INJECTION | Dr Reddys Laboratories Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| July 29, 2021 | THYROGEN | Sanofi Genzyme, A Division Of Sanofi-Aventis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 29, 2021 | TEVA-IRBESARTAN HCTZ | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 29, 2021 | INVOKANA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 29, 2021 | TEVA-FULVESTRANT INJECTION | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 29, 2021 | RILUTEK | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 29, 2021 | INTERCEPTOR PLUS | Elanco Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 29, 2021 | APO-WARFARIN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 29, 2021 | APO-CLOPIDOGREL | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 29, 2021 | VIZIMPRO | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| July 29, 2021 | BENLYSTA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 29, 2021 | JANUVIA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 28, 2021 | VABLYS | Duchesnay Inc. | New Drug Submission (NDS) · Other |
| July 28, 2021 | FLUOROURACIL INJECTION USP | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 28, 2021 | TEVA-MIRTAZAPINE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 28, 2021 | JANUMET; JANUMET XR | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 28, 2021 | TEVA-BROMAZEPAM | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 27, 2021 | MONUROL | Paladin Labs Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 27, 2021 | LENVIMA | Eisai Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 27, 2021 | STRIBILD | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 27, 2021 | RINVOQ | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| July 27, 2021 | BUPIVACAINE INJECTION BP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 27, 2021 | CEFTIN | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 27, 2021 | SOLENSIA | Zoetis Canada Inc | New Drug Submission (NDS) · Other |
| July 26, 2021 | AREPANRIX H5N1 | Id Biomedical Corporation Of Quebec | Supplement to a New Drug Submission (SNDS) · Other |
| July 26, 2021 | KETOROLAC TROMETHAMINE INJECTION, USP | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 26, 2021 | VINCRISTINE SULFATE INJECTION USP | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| July 26, 2021 | LEQVIO | Novartis Pharmaceuticals Canada Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| July 26, 2021 | TEVA-IRBESARTAN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 26, 2021 | GILENYA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 26, 2021 | MAR-FEBUXOSTAT | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 26, 2021 | PROCYSBI | Horizon Therapeutics Ireland Dac | Supplement to a New Drug Submission (SNDS) · Other |
| July 23, 2021 | DYSPORT AWSTHETIC; DYSPORT THERAPEUTIC | Ipsen Biopharmaceuticals Canada Inc | New Drug Submission (NDS) · Labelling Only |
| July 23, 2021 | RABAVERT | Bavarian Nordic As | Supplement to a New Drug Submission (SNDS) · Other |
| July 23, 2021 | TRESIBA | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 23, 2021 | FIASP | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 23, 2021 | BIO-ESCITALOPRAM | Biomed Pharma | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 23, 2021 | APO-ABACAVIR-LAMIVUDINE TABLETS | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 23, 2021 | AURO-MIRTAZAPINE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 23, 2021 | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| July 23, 2021 | ACT VENLAFAXINE XR | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 23, 2021 | SANDOZ FINGOLIMOD | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 22, 2021 | CHAMPIX | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| July 22, 2021 | BRUKINSA | Beigene Switzerland Gmbh | New Drug Submission (NDS) · Other |
| July 22, 2021 | APO-FAMCICLOVIR | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 22, 2021 | ERTAPENEM FOR INJECTION | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 21, 2021 | REXXOLIDE | Dechra Regulatory Bv | Abbreviated New Drug Submission (ANDS) · Other |
| July 21, 2021 | TELMISARTAN-HCTZ | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 21, 2021 | ZESTORETIC | Searchlight Pharma Inc. | New Drug Submission (NDS) · Admin |
| July 21, 2021 | PMSC-ESCITALOPRAM | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 21, 2021 | PREZISTA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 21, 2021 | PREZCOBIX | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 21, 2021 | AXID | Pendopharm Division Of Pharmascience Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 21, 2021 | FOSAMAX | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 21, 2021 | UPTRAVI | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 21, 2021 | DULOXETINE | Alembic Pharmaceuticals Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 21, 2021 | APO-ONDANSETRON | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 21, 2021 | MINT-PAROXETINE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 21, 2021 | TEVA-LEVOCARBIDOPA | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 21, 2021 | LUVOX | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| July 20, 2021 | GLN-OLMESARTAN HCTZ | Glenmark Pharmaceuticals Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 20, 2021 | TEVA-FAMOTIDINE | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 20, 2021 | CLOMICALM | Virbac Animal Health Inc | New Drug Submission (NDS) · Admin |
| July 20, 2021 | CLOMICALM | Virbac Animal Health Inc | New Drug Submission (NDS) · Admin |
| July 20, 2021 | CLOMICALM | Virbac Animal Health Inc | New Drug Submission (NDS) · Admin |
| July 19, 2021 | XOLAIR | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 19, 2021 | PLAQUENIL | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 19, 2021 | SYMTUZA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 19, 2021 | APO-RAMIPRIL | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 19, 2021 | SANDOZ OLMESARTAN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 19, 2021 | BROMAZEPAM | Apotex Inc. | New Drug Submission (NDS) · Other |
| July 16, 2021 | FORADIL | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 16, 2021 | NIASTASE RT | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 16, 2021 | IBRANCE | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| July 16, 2021 | NERLYNX | Knight Therapeutics Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 16, 2021 | OSPHENA | Duchesnay Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| July 15, 2021 | WINDEX MULTI-SURFACE ANTIBACTERIAL DISINFECTANT 2 | S.C. Johnson and Son Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 15, 2021 | BREZTRI AEROSPHERE | Astrazeneca Canada Inc | New Drug Submission (NDS) · Other |
| July 15, 2021 | NUBEQA | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 15, 2021 | CONDYLINE | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 15, 2021 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 15, 2021 | ATENOLOL | Pro Doc Limitee | Supplement to a New Drug Submission (SNDS) · Admin |
| July 15, 2021 | TEVA-SPIRONOLACTONE/HCTZ | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 15, 2021 | M-PAROXETINE | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 15, 2021 | PAROXETINE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 15, 2021 | RIVA-MONTELUKAST FC | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 15, 2021 | TAVALISSE | Medison Pharma Canada Inc. | New Drug Submission (NDS) · Admin |
| July 15, 2021 | NALOXONE HYDROCHLORIDE INJECTION, USP | Baxter Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| July 15, 2021 | APO-ELETRIPTAN TABLETS | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 15, 2021 | AURO-MIRTAZAPINE OD | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 15, 2021 | OVIMA 21; OVIMA 28 | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 15, 2021 | DIACOMIT | Biocodex Sas | Supplement to a New Drug Submission (SNDS) · Other |
| July 15, 2021 | TARO-METHYLPREDNISOLONE INJECTION | Taro Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| July 15, 2021 | OCTREOTIDE FOR INJECTABLE SUSPENSION | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 14, 2021 | ENTRESTO | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 14, 2021 | PROZAC | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 14, 2021 | ERTAPENEM FOR INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 14, 2021 | VIRAZOLE | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 14, 2021 | COPAXONE | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 13, 2021 | ACH-FINASTERIDE | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 13, 2021 | SANDOZ ATOMOXETINE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 13, 2021 | EDARBYCLOR | Bausch Health, Canada Inc. | New Drug Submission (NDS) · Labelling Only |
| July 13, 2021 | EDARBI | Bausch Health, Canada Inc. | New Drug Submission (NDS) · Labelling Only |
| July 12, 2021 | LUPIN-PROPRANOLOL LA | Lupin Pharma Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 12, 2021 | IRINOTECAN HYDROCHLORIDE INJECTION USP | Pfizer Canada Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 12, 2021 | REMIFENTANIL HYDROCHLORIDE FOR INJECTION | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 9, 2021 | SYNAGIS | Astrazeneca Canada Inc | New Drug Submission (NDS) · Admin |
| July 9, 2021 | AMGEVITA | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 9, 2021 | OPDIVO | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| July 9, 2021 | TUKYSA | Seagen Inc. | New Drug Submission (NDS) · Admin |
| July 9, 2021 | NORVIR | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| July 9, 2021 | MIRVALA 28; MIRVALA 21 | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 9, 2021 | MINT-DULOXETINE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 9, 2021 | KALETRA | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| July 9, 2021 | NAT-LANTHANUM | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 9, 2021 | VYNDAMAX | Pfizer Canada Ulc | New Drug Submission (NDS) · Other |
| July 9, 2021 | ROCURONIUM BROMIDE INJECTION | Hikma Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| July 8, 2021 | APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 8, 2021 | GEMCITABINE FOR INJECTION | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 8, 2021 | ROCURONIUM BROMIDE INJECTION | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 8, 2021 | TARO-IRBESARTAN | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 8, 2021 | NRA-TRAMADOL/ACET | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 8, 2021 | MELPHALAN FOR INJECTION | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 8, 2021 | MAR-METOCLOPRAMIDE | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| July 8, 2021 | ARAZLO | Bausch Health, Canada Inc. | New Drug Submission (NDS) · Other |
| July 8, 2021 | JAMP MIDODRINE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| July 7, 2021 | PMS-DOXYCYCLINE | Pharmascience Inc. | New Drug Submission (NDS) · Admin |
| July 7, 2021 | AURO-ARIPIPRAZOLE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 7, 2021 | MYLAN-FINGOLIMOD | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 7, 2021 | AGRYLIN | Takeda Canada Incorporated | New Drug Submission (NDS) · Labelling Only |
| July 7, 2021 | LEVODOPA, CARBIDOPA AND ENTACAPONE TABLETS | Strides Pharma Canada Inc | Abbreviated New Drug Submission (ANDS) · Other |
| July 7, 2021 | PMS-CINACALCET | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 7, 2021 | SANDOZ TOBRAMYCIN / DEXAMETHASONE | Sandoz Canada Inc. | New Drug Submission (NDS) · Admin |
| July 7, 2021 | ARIMIDEX | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 7, 2021 | ERLEADA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 6, 2021 | CETIRIZINE; CETIRIZINE EXTRA STRENGTH | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| July 6, 2021 | TYPHIM VI | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 6, 2021 | ROSUVASTATIN | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 6, 2021 | REDDY-ATORVASTATIN | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 6, 2021 | SANDOZ MIRTAZAPINE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 6, 2021 | MINT-VALGANCICLOVIR | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 6, 2021 | OFEV | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| July 6, 2021 | SANDOZ TACROLIMUS | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 6, 2021 | CAELYX | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 6, 2021 | PMS-SILODOSIN | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| July 5, 2021 | HYOSCINE BUTYLBROMIDE INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 5, 2021 | TEVA-ATORVASTATIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 5, 2021 | OLOPATADINE OPHTHALMIC SOLUTION | Beximco Pharmaceuticals Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 5, 2021 | PENTAMIDINE ISETIONATE FOR INJECTION BP | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| July 5, 2021 | EXTRA STRENGTH CLOTRIMAZOLE EXTRA FORT -FLUCONAZOLE COMBI | Taro Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| July 5, 2021 | QTERN | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 5, 2021 | KOMBOGLYZE | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 5, 2021 | TEVA-SILDENAFIL | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 5, 2021 | VOLIBRIS | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 5, 2021 | APO-METHOTREXATE | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| July 2, 2021 | OPDIVO | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| July 2, 2021 | CUROSURF | Chiesi Farmaceutici S.P.A. | Supplement to a New Drug Submission (SNDS) · Other |
| July 2, 2021 | ALPROLIX | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 2, 2021 | FLUCELVAX QUAD | Seqirus Uk Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 2, 2021 | FLUAD; FLUAD PEDIATRIC | Seqirus Uk Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 2, 2021 | ALECENSARO | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 2, 2021 | PENTAMIDINE ISETIONATE FOR INJECTION BP | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| July 2, 2021 | PEMETREXED DISODIUM FOR INJECTION | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| June 30, 2021 | RIXIMYO | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 30, 2021 | GAVRETO | Hoffmann-La Roche Limited | New Drug Submission (NDS) · New Active Substance (NAS) |
| June 30, 2021 | DARZALEX | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 30, 2021 | SANDOZ VALSARTAN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 30, 2021 | BRIVLERA | Ucb Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 30, 2021 | DULOXETINE DR | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 30, 2021 | MAR-ESCITALOPRAM | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 30, 2021 | PMS-MIRTAZAPINE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 30, 2021 | NETSPOT | Advanced Accelerator Applications Usa, Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 30, 2021 | ONGLYZA | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 30, 2021 | MELOXICAM | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 30, 2021 | MUSCLE AND BACK PAIN PLATINUM RELIEF | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 30, 2021 | COMBOGESIC | BioSyent Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 30, 2021 | RAN-DULOXETINE | Ranbaxy Pharmaceuticals Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 30, 2021 | ODAN CLOBETASOL SPRAY | Odan Laboratories Ltd. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 30, 2021 | PAT-GALANTAMINE ER | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 30, 2021 | RYDAPT | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 30, 2021 | RIVA-ATENOLOL | Laboratoire Riva Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| June 30, 2021 | JAMP-DORZOLAMIDE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 30, 2021 | RIVA-CLOPIDOGREL | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 30, 2021 | PRO-LEVETIRACETAM - 250; PRO-LEVETIRACETAM - 500; PRO-LEVETIRACETAM - 750 | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 30, 2021 | ESCITALOPRAM | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 30, 2021 | ATORVASTATIN | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 30, 2021 | TOPIRAMATE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 30, 2021 | NAT-BENDAMUSTINE | Natco Pharma (Canada) Inc | Abbreviated New Drug Submission (ANDS) · Other |
| June 29, 2021 | ABRILADA | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| June 29, 2021 | ZYVOXAM | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| June 29, 2021 | NEXHA | Vetoquinol N A Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 29, 2021 | JAKAVI | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 29, 2021 | ITRAFUNGOL | Virbac Animal Health Inc | New Drug Submission (NDS) · Admin |
| June 29, 2021 | RHEUMOCAM INJECTION | Chanelle Pharmaceuticals Manufacturing Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 29, 2021 | METRICURE | Intervet Canada Corp | Supplement to a New Drug Submission (SNDS) · Other |
| June 29, 2021 | DORMAZOLAM | Dechra Regulatory Bv | New Drug Submission (NDS) · Other |
| June 29, 2021 | TEVA-PANTOPRAZOLE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 29, 2021 | JAMP QUINAPRIL | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| June 29, 2021 | PMSC-CELECOXIB | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| June 28, 2021 | LOPERAMIDE-2 | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 28, 2021 | MAXIDOL LIQUID GELS | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 28, 2021 | ATRIDOX | Den-Mat Holdings, LLC | Supplement to a New Drug Submission (SNDS) · Other |
| June 28, 2021 | TEVA-SILDENAFIL R | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 28, 2021 | TEVA-LANSOPRAZOLE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 28, 2021 | MYLAN-PANTOPRAZOLE T | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 28, 2021 | APO-VORICONAZOLE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 28, 2021 | DEXMEDETOMIDINE HYDROCHLORIDE INJECTION | Juno Pharmaceuticals Corp. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 28, 2021 | APO-SALBUTAMOL HFA | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| June 28, 2021 | FLUCONAZOLE | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 28, 2021 | APO-MONTELUKAST SODIUM; APO-MONTELUKAST SODIUM CHEWABLE | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| June 25, 2021 | TRECONDYV | Medexus Inc | New Drug Submission (NDS) · Priority |
| June 25, 2021 | EPCLUSA | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 25, 2021 | SOVALDI | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 25, 2021 | HARVONI | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 25, 2021 | SYNALAR | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 25, 2021 | RALIVIA | Bausch Health, Canada Inc. | New Drug Submission (NDS) · Other |
| June 25, 2021 | OFEV | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| June 25, 2021 | SANDOZ TELMISARTAN HCT | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 25, 2021 | JAMP CETIRIZINE TABLETS | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| June 24, 2021 | DUPIXENT | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 24, 2021 | ERELZI | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 24, 2021 | APO-CEFADROXIL | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 24, 2021 | APO-MEGESTROL | Apotex Inc. | New Drug Submission (NDS) · Admin |
| June 24, 2021 | AVALIDE | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 24, 2021 | AVAPRO | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 24, 2021 | MANERIX | Bausch Health, Canada Inc. | New Drug Submission (NDS) · Labelling Only |
| June 24, 2021 | JARDIANCE | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| June 24, 2021 | NITROLINGUAL PUMPSPRAY | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 23, 2021 | NERLYNX | Knight Therapeutics Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 23, 2021 | AURO-IRBESARTAN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 23, 2021 | TARO-OXALIPLATIN | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 23, 2021 | LIBTAYO | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 22, 2021 | TRAJENTA | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| June 22, 2021 | PMS-AMPHETAMINES XR | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 22, 2021 | INDERAL-LA | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| June 22, 2021 | VASOTEC | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 21, 2021 | CIPRO; CIPRO ORAL SUSPENSION | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Labelling Only |
| June 21, 2021 | SANDOZ ADAPALENE / BENZOYL PEROXIDE FORTE; SANDOZ ADAPALENE/BENZOYL PEROXIDE | Sandoz Canada Inc. | New Drug Submission (NDS) · Admin |
| June 21, 2021 | NPLATE | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 21, 2021 | SANDOZ VALSARTAN HCT | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 21, 2021 | TIROCAP | Ibsa Institut Biochimique Sa | Supplement to a New Drug Submission (SNDS) · Labelling Only |
| June 21, 2021 | SANDOZ OLMESARTAN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 21, 2021 | RAN-ESOMEPRAZOLE | Ranbaxy Pharmaceuticals Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 21, 2021 | KETAMINE HYDROCHLORIDE INJECTION USP | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 21, 2021 | ATHENA-ONDANSETRON ODT | Athena Pharmaceutiques Sas | Abbreviated New Drug Submission (ANDS) · Admin |
| June 21, 2021 | RIVA-DORZOLAMIDE/TIMOLOL | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 21, 2021 | ACH-ESCITALOPRAM | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 21, 2021 | JAMP-CLOPIDOGREL | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 21, 2021 | ZOLEDRONIC ACID INJECTION A | Pfizer Canada Ulc | Abbreviated New Drug Submission (ANDS) · Other |
| June 18, 2021 | ESOMEPRAZOLE | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| June 18, 2021 | TRAZIMERA | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| June 18, 2021 | CEFA-LAK | Boehringer Ingelheim Animal Health Canada Inc. | New Drug Submission (NDS) · Admin |
| June 18, 2021 | RBX-ATORVASTATIN | Sun Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| June 18, 2021 | PANTOPRAZOLE FOR INJECTION | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 18, 2021 | APO-MOXIFLOXACIN HYDROCHLORIDE | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| June 18, 2021 | APO-OXYCODONE CR | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 18, 2021 | HEMANGIOL | Pierre Fabre Dermo-Cosmetique Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 18, 2021 | DOCETAXEL INJECTION USP | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| June 18, 2021 | TARO-BUPRENORPHINE/NALOXONE | Taro Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| June 18, 2021 | TRIKAFTA | Vertex Pharmaceuticals (Canada) Incorporated | New Drug Submission (NDS) · Priority-NAS |
| June 18, 2021 | APO-CYCLOBENZAPRINE | Apotex Inc. | New Drug Submission (NDS) · Admin |
| June 18, 2021 | BIO-ATORVASTATIN | Biomed Pharma | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 17, 2021 | RETROVIR (AZT) | Viiv Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| June 17, 2021 | PMS-IRBESARTAN-HCTZ | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 17, 2021 | MYFORTIC | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 17, 2021 | JAMP VANCOMYCIN | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| June 16, 2021 | APO-AMOXI CLAV | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 16, 2021 | AURO-SILODOSIN | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| June 16, 2021 | SANDOZ METFORMIN XR | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 15, 2021 | CUTAQUIG | Octapharma Pharmazeutika Produktionsges M B H | Supplement to a New Drug Submission (SNDS) · Other |
| June 15, 2021 | TYPHIM VI | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 15, 2021 | CUROSURF | Chiesi Farmaceutici S.P.A. | Supplement to a New Drug Submission (SNDS) · Other |
| June 15, 2021 | BIVALIRUDIN FOR INJECTION | Juno Pharmaceuticals Corp. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 15, 2021 | RETEVMO | Loxo Oncology Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| June 15, 2021 | PIQRAY | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 15, 2021 | CEFA-DRI | Boehringer Ingelheim Animal Health Canada Inc. | New Drug Submission (NDS) · Admin |
| June 15, 2021 | PMS-ABIRATERONE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 15, 2021 | POLYFLEX | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| June 14, 2021 | BETAHISTINE | Surax Healthcare Inc | Abbreviated New Drug Submission (ANDS) · Other |
| June 14, 2021 | TOPIRAMATE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 14, 2021 | NORDITROPIN NORDIFLEX | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 14, 2021 | IMFINZI | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 14, 2021 | PANTOPRAZOLE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 14, 2021 | AG-QUETIAPINE FUMARATE | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 14, 2021 | BUPROPION HCL SR | Bausch Health, Canada Inc. | New Drug Submission (NDS) · Admin |
| June 14, 2021 | METACAM | Boehringer Ingelheim Animal Health Canada Inc. | New Drug Submission (NDS) · Admin |
| June 14, 2021 | METACAM | Boehringer Ingelheim Animal Health Canada Inc. | New Drug Submission (NDS) · Admin |
| June 14, 2021 | IPG-AMLODIPINE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 14, 2021 | SANDOZ IRBESARTAN HCT | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 14, 2021 | VASERETIC | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 14, 2021 | VANCOMYCIN HYDROCHLORIDE FOR INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 14, 2021 | APO-CARBAMAZEPINE | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 11, 2021 | TECENTRIQ | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 11, 2021 | ROSUVASTATIN | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 11, 2021 | WELLBUTRIN XL | Bausch Health, Canada Inc. | New Drug Submission (NDS) · Labelling Only |
| June 11, 2021 | TRYPTAN | Bausch Health, Canada Inc. | New Drug Submission (NDS) · Labelling Only |
| June 11, 2021 | APO-QUINAPRIL/HCTZ | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 11, 2021 | APO-CLONAZEPAM | Apotex Inc. | New Drug Submission (NDS) · Admin |
| June 11, 2021 | ADCETRIS | Seagen Inc. | New Drug Submission (NDS) · Admin |
| June 11, 2021 | RIZATRIPTAN | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 10, 2021 | BMD 110 G | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 10, 2021 | SANDOZ LANSOPRAZOLE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 10, 2021 | MAR-ATORVASTATIN | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 10, 2021 | MED-VORICONAZOLE | Generic Medical Partners Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 10, 2021 | MYLAN-ATAZANAVIR | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 10, 2021 | IPG-PANTOPRAZOLE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 10, 2021 | PRASCEND | Boehringer Ingelheim Animal Health Canada Inc. | New Drug Submission (NDS) · Admin |
| June 10, 2021 | APO-ATENOL | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 10, 2021 | IDAMYCIN PFS | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| June 10, 2021 | CELLCEPT; CELLCEPT I.V. | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 10, 2021 | RAVICTI | Horizon Therapeutics Ireland Dac | Supplement to a New Drug Submission (SNDS) · Other |
| June 10, 2021 | JAMP TEMOZOLOMIDE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| June 10, 2021 | DRY-CLOX | Boehringer Ingelheim Animal Health Canada Inc. | New Drug Submission (NDS) · Admin |
| June 10, 2021 | TEVA-FLUOXETINE | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 10, 2021 | ORGALUTRAN | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 10, 2021 | APO-PANTOPRAZOLE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 10, 2021 | EFUDEX | Bausch Health, Canada Inc. | New Drug Submission (NDS) · Labelling Only |
| June 10, 2021 | MONOVET | Huvepharma Eood | Abbreviated New Drug Submission (ANDS) · Other |
| June 9, 2021 | NORDITROPIN NORDIFLEX | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 9, 2021 | ZOLGENSMA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 9, 2021 | UROCIT-K | Mission Pharmacal Company | Supplement to a New Drug Submission (SNDS) · Other |
| June 9, 2021 | ALTACE HCT | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 9, 2021 | TAPAZOLE | Paladin Labs Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 8, 2021 | MAR-PALIPERIDONE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 8, 2021 | TEVA-LEVETIRACETAM | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 8, 2021 | MENVEO | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 8, 2021 | TECARTUS | Gilead Sciences Canada Inc | New Drug Submission (NDS) · Priority-NAS |
| June 8, 2021 | LEDAGA | Recordati Rare Diseases Canada Inc | New Drug Submission (NDS) · Other |
| June 8, 2021 | POLYFLEX | Boehringer Ingelheim Animal Health Canada Inc. | New Drug Submission (NDS) · Admin |
| June 8, 2021 | APO-BACLOFEN | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 7, 2021 | TOVIAZ | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Labelling Only |
| June 7, 2021 | APO-THEO ER | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 7, 2021 | AURO-PREGABALIN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 7, 2021 | LORBRENA | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| June 7, 2021 | FASENRA AND FASENRA PEN | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 7, 2021 | GANCICLOVIR FOR INJECTION USP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 7, 2021 | PANTOPRAZOLE FOR INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 7, 2021 | PANTOPRAZOLE SODIUM FOR INJECTION | Generic Medical Partners Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 7, 2021 | PROPOFOL INJECTION | Baxter Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 4, 2021 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Priority |
| June 4, 2021 | SURVANTA | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| June 4, 2021 | QUETIAPINE FUMARATE XR | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 4, 2021 | BIO-SOLIFENACIN | Biomed Pharma | Abbreviated New Drug Submission (ANDS) · Admin |
| June 4, 2021 | LYNPARZA | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 4, 2021 | AURO-IRBESARTAN HCT | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 4, 2021 | TIAZAC | Bausch Health, Canada Inc. | New Drug Submission (NDS) · Labelling Only |
| June 4, 2021 | ASPIRIN 81 MG; ASPIRIN 81 MG QUICK CHEWS; ASPIRIN EXTRA STRENGTH; ASPIRIN REGULAR STRENGTH | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 4, 2021 | NABUMETONE | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| June 4, 2021 | TRILEPTAL | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 4, 2021 | COLD & SINUS RELIEF CAPSULES | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 4, 2021 | ZYBAN | Bausch Health, Canada Inc. | New Drug Submission (NDS) · Labelling Only |
| June 4, 2021 | TIAZAC XC | Bausch Health, Canada Inc. | New Drug Submission (NDS) · Labelling Only |
| June 4, 2021 | SANDOZ ZOPICLONE TABLET | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 4, 2021 | AQUALIFE TMS | Syndel Canada | Supplement to a New Drug Submission (SNDS) · Other |
| June 4, 2021 | LOPERACAP | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 4, 2021 | TEVA-RASAGILINE | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 4, 2021 | ALLERGY RELIEF CETIRIZINE HYDROCHLORIDE LIQUID GELS | Strides Pharma Canada Inc | Abbreviated New Drug Submission (ANDS) · Other |
| June 4, 2021 | DRAXXIN KP | Zoetis Canada Inc | New Drug Submission (NDS) · Other |
| June 3, 2021 | VENLAFAXINE XR | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| June 3, 2021 | GLYCOPYRRONIUM (AS BROMIDE) / FORMOTEROL FUMARATE DIHYDRATE PRESSURIZED INHALATION AEROSOL | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Admin |
| June 3, 2021 | 99MTC SULPHIDE COLLOID KIT | Isologic Innovative Radiopharmaceuticals Ltd. | New Drug Submission (NDS) · Admin |
| June 3, 2021 | AZILECT | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| June 3, 2021 | AG-FLECAINIDE | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 3, 2021 | ONDANSETRON ODT | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Labelling Only |
| June 3, 2021 | NIVESTYM (FILGRASTIM PF-06881893) | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| June 3, 2021 | NYVEPRIA | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| June 3, 2021 | VALIUM | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 3, 2021 | RIVOTRIL | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 3, 2021 | RINVOQ | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| June 3, 2021 | ERLEADA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 3, 2021 | APO-ABIRATERONE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 2, 2021 | AVAXIM | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 2, 2021 | COSENTYX | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 2, 2021 | PMS-IRBESARTAN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 2, 2021 | IMBRUVICA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 2, 2021 | CLOZARIL | Hls Therapeutics Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 2, 2021 | KYPROLIS | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 2, 2021 | KETOROLAC TROMETHAMINE INJECTION USP | Pfizer Canada Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 2, 2021 | SKYRIZI | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| June 1, 2021 | BRICANYL TURBUHALER | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 1, 2021 | DOMPERIDONE | Sanis Health Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| June 1, 2021 | NALOXONE INJECTABLE | Telip, Llc, A Subsidiary Of Teligent, Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 1, 2021 | AG-TENOFOVIR | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 1, 2021 | MENOPUR | Ferring Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 1, 2021 | JAMP DARIFENACIN | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| June 1, 2021 | CEPHALEXIN - 500 | Pro Doc Limitee | Supplement to a New Drug Submission (SNDS) · Admin |
| June 1, 2021 | PMS-DESONIDE | Pharmascience Inc. | New Drug Submission (NDS) · Admin |
| June 1, 2021 | IRINOTECAN HYDROCHLORIDE INJECTION | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 1, 2021 | INCREXXA | Elanco Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| May 31, 2021 | PRAMIPEXOLE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 31, 2021 | AG-AMLODIPINE | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 31, 2021 | VENTIPULMIN | Boehringer Ingelheim Animal Health Canada Inc. | New Drug Submission (NDS) · Admin |
| May 31, 2021 | SANDOZ AMIODARONE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 28, 2021 | AVAXIM PEDIATRIC | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| May 28, 2021 | RUBY-FILL | Jubilant Draximage Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 28, 2021 | NAT-PREGABALIN | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 28, 2021 | OPDIVO | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| May 28, 2021 | TIBELLA | BioSyent Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 28, 2021 | PRINIVIL | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 28, 2021 | TEGRETOL | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 27, 2021 | ADVATE | Takeda Canada Incorporated | New Drug Submission (NDS) · Labelling Only |
| May 27, 2021 | DIVALPROEX | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| May 27, 2021 | TEPMETKO | Emd Serono A Division Of Emd Inc Canada | New Drug Submission (NDS) · New Active Substance (NAS) |
| May 27, 2021 | HYDRALAZINE HYDROCHLORIDE INJECTION, USP | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 27, 2021 | BIO-PAROXETINE | Biomed Pharma | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 27, 2021 | VISKAZIDE | Xediton Pharmaceuticals Inc. | New Drug Submission (NDS) · Admin |
| May 27, 2021 | PMS-FLUTICASONE; PMS-FLUTICASONE HFA | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| May 27, 2021 | FLUCONAZOLE 150 | Taro Pharmaceuticals Inc | Supplement to a New Drug Submission (SNDS) · Admin |
| May 27, 2021 | PROGESTERONE | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 27, 2021 | CEFTRIAXONE SODIUM FOR INJECTION | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 27, 2021 | ZYTIGA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 27, 2021 | COLD + SINUS | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 27, 2021 | COLD + SINUS PLUS | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 26, 2021 | ABECMA | Celgene Inc | New Drug Submission (NDS) · Priority-NAS |
| May 26, 2021 | COSENTYX | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 26, 2021 | SANDOZ IRBESARTAN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 26, 2021 | RBX-CLOPIDOGREL | Ranbaxy Pharmaceuticals Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 26, 2021 | SONOVUE | Bracco Imaging Canada | Supplement to a New Drug Submission (SNDS) · Other |
| May 26, 2021 | XYLOCARD | Aspen Pharmacare Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 26, 2021 | AZACITIDINE FOR INJECTION | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 26, 2021 | DILTIAZEM T | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 25, 2021 | WAKIX | Endo Ventures Ltd | New Drug Submission (NDS) · New Active Substance (NAS) |
| May 25, 2021 | ACT DILTIAZEM T | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 25, 2021 | SANDOZ CLOPIDOGREL | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 25, 2021 | CASPOFUNGIN FOR INJECTION | Juno Pharmaceuticals Corp. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| May 21, 2021 | LANTUS | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 21, 2021 | VOSEVI | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 21, 2021 | JANUVIA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 21, 2021 | JANUMET; JANUMET XR | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 21, 2021 | JAMP EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 21, 2021 | PMS-ATENOLOL | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 21, 2021 | SANDOZ CLONIDINE | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 21, 2021 | BIKTARVY | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 20, 2021 | DICLOFENAC SODIUM SOLUTION | Telip, Llc, A Subsidiary Of Teligent, Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 20, 2021 | APO-ONDANSETRON | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 20, 2021 | TARO-TEMOZOLOMIDE | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 20, 2021 | TRURAPI | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 20, 2021 | ADMELOG; ADMELOG SOLOSTAR | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 20, 2021 | HYDROMORPHONE HP 10; HYDROMORPHONE HP 20; HYDROMORPHONE HP 50; HYDROMORPHONE HP FORTE INJECTION | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 19, 2021 | APO-ABIRATERONE ACETATE FILM COATED TABLETS | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 19, 2021 | VERAPAMIL HYDROCHLORIDE INJECTION USP | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| May 19, 2021 | IPG-ESCITALOPRAM | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 19, 2021 | ANDROCUR; ANDROCUR DEPOT | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 19, 2021 | DIASTAT | Valeant Pharmaceuticals North America Llc | Supplement to a New Drug Submission (SNDS) · Other |
| May 19, 2021 | PANZYGA | Octapharma Pharmazeutika Produktionsges M B H | Supplement to a New Drug Submission (SNDS) · Other |
| May 19, 2021 | APO-ABIRATERONE ACETATE FILM COATED TABLETS | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 19, 2021 | ILUMYA | Sun Pharma Global Fze | New Drug Submission (NDS) · New Active Substance (NAS) |
| May 18, 2021 | APIDRA | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 18, 2021 | EUCRISA | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| May 18, 2021 | JAMP PIRFENIDONE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| May 18, 2021 | JAMP PIRFENIDONE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| May 18, 2021 | TEVA-PIRFENIDONE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 18, 2021 | TEVA-PIRFENIDONE | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| May 18, 2021 | OCTASA | Tillotts Pharma Gmbh | New Drug Submission (NDS) · Other |
| May 17, 2021 | SANDOZ SILODOSIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 17, 2021 | APO-DASATINIB | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 17, 2021 | ULTRAVATE | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 17, 2021 | TISSEEL | Baxter Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| May 17, 2021 | ATIVAN | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| May 14, 2021 | VISKEN | Xediton Pharmaceuticals Inc. | New Drug Submission (NDS) · Admin |
| May 14, 2021 | LEVETIRACETAM | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 14, 2021 | RIVA-PAROXETINE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 14, 2021 | PROPAFENONE | Sanis Health Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| May 14, 2021 | SANDOZ TOPIRAMATE TABLETS | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 14, 2021 | DICLOFENAC K | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 14, 2021 | IRINOTECAN HYDROCHLORIDE INJECTION | Telip, Llc, A Subsidiary Of Teligent, Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 14, 2021 | ODAN BUPROPION SR | Odan Laboratories Ltd. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 14, 2021 | MYLAN-INDAPAMIDE | Mylan Pharmaceuticals Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| May 14, 2021 | SANDOZ VORICONAZOLE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 14, 2021 | IPG-ONDANSETRON | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 14, 2021 | SANDOZ ATORVASTATIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 14, 2021 | APO-FLUCONAZOLE | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 14, 2021 | EYLEA | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 14, 2021 | HULIO | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| May 14, 2021 | MAR-DARUNAVIR | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 14, 2021 | APO-AMLODIPINE-ATORVASTATIN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 14, 2021 | MYLAN-BACLOFEN | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 14, 2021 | TOPAMAX | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 14, 2021 | SEVORANE AF | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| May 14, 2021 | LORAZEPAM INJECTION USP | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 14, 2021 | DIAZEPAM INJECTION USP | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 14, 2021 | ALKERAN | Aspen Pharmacare Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 14, 2021 | ACH-TADALAFIL | Accord Healthcare Inc | Abbreviated New Drug Submission (ANDS) · Other |
| May 13, 2021 | LUTATHERA | Advanced Accelerator Applications Usa, Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 13, 2021 | PMS-CLOPIDOGREL | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 13, 2021 | PANTOPRAZOLE SODIUM FOR INJECTION | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| May 13, 2021 | VITRAKVI | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 13, 2021 | SUNOSI | Jazz Pharmaceuticals Ireland Limited | New Drug Submission (NDS) · New Active Substance (NAS) |
| May 13, 2021 | PMSC-RIVAROXABAN | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| May 13, 2021 | NAPROXEN MENSTRUAL PAIN RELIEF | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 13, 2021 | CLOTRIMAZOLE EXTERNAL ANTIFUNGAL CREAM; CLOTRIMAZOLE VAGINAL 3; CLOTRIMAZOLE VAGINAL 6 | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 13, 2021 | SANDOZ CLONIDINE | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 12, 2021 | CEFEPIME FOR INJECTION USP | Telip, Llc, A Subsidiary Of Teligent, Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 12, 2021 | BACLOFEN INJECTION | Telip, Llc, A Subsidiary Of Teligent, Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 12, 2021 | MAXALT; MAXALT RPD | Organon Canada Inc. | New Drug Submission (NDS) · Admin |
| May 12, 2021 | NASONEX | Organon Canada Inc. | New Drug Submission (NDS) · Admin |
| May 12, 2021 | FOSAVANCE | Organon Canada Inc. | New Drug Submission (NDS) · Admin |
| May 12, 2021 | PANTOPRAZOLE FOR INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 12, 2021 | TOLOXIN | Pendopharm Division Of Pharmascience Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 12, 2021 | PRIVIGEN | Csl Behring Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 12, 2021 | APO-RISEDRONATE DR | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 11, 2021 | BENZAMYCIN | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 11, 2021 | TRELEGY ELLIPTA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 11, 2021 | CLINDAMYCIN PHOSPHATE TOPICAL SOLUTION USP | Telip, Llc, A Subsidiary Of Teligent, Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 11, 2021 | DOBUTAMINE INJECTION USP | Telip, Llc, A Subsidiary Of Teligent, Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 11, 2021 | REMERON RD | Organon Canada Inc. | New Drug Submission (NDS) · Admin |
| May 11, 2021 | M-PILOCARPINE | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 11, 2021 | SANDOZ IMATINIB | Sandoz Canada Inc. | New Drug Submission (NDS) · Admin |
| May 11, 2021 | CETIRIZINE | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 11, 2021 | AUBAGIO | Sanofi Genzyme, A Division Of Sanofi-Aventis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 11, 2021 | OFEV | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| May 10, 2021 | AMOXICILLIN | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 10, 2021 | PREGABALIN | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 10, 2021 | RIVA-PANTOPRAZOLE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 10, 2021 | SANDOZ TRAVOPROST / TIMOLOL PQ | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| May 10, 2021 | JAMP-VARDENAFIL | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 10, 2021 | APO-ABACAVIR | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 10, 2021 | MINT-HYDROXYCHLOROQUINE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 7, 2021 | TEVA-BUPROPION XL | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 7, 2021 | FOSAMAX | Organon Canada Inc. | New Drug Submission (NDS) · Admin |
| May 7, 2021 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 7, 2021 | ONDANSETRON HYDROCHLORIDE DIHYDRATE INJECTION; ONDANSETRON INJECTION USP (PRESERVATIVE FREE); ONDANSETRON INJECTION USP (WITH PRESERVATIVE); SANDOZ ONDANSETRON | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 7, 2021 | DEPAKENE | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| May 7, 2021 | APO-CLOBAZAM | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 6, 2021 | XOFLUZA | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| May 6, 2021 | EPIVAL | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| May 6, 2021 | BLINCYTO | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 6, 2021 | SYNAGIS | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| May 6, 2021 | BEXSERO | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 6, 2021 | AFINITOR; AFINITOR DISPERZ | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 6, 2021 | BACLOFEN INJECTION | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 6, 2021 | MAYZENT | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 6, 2021 | ENTRESTO | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 5, 2021 | LAMOTRIGINE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 5, 2021 | RIVA-ZOPICLONE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 5, 2021 | REMERON | Organon Canada Inc. | New Drug Submission (NDS) · Admin |
| May 5, 2021 | SINGULAIR | Organon Canada Inc. | New Drug Submission (NDS) · Admin |
| May 5, 2021 | AMLODIPINE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 5, 2021 | XYDALBA | Endo Ventures Ltd | New Drug Submission (NDS) · Admin |
| May 5, 2021 | OLANZAPINE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 5, 2021 | URSODIOL C | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 5, 2021 | ASA 81 MG | Laboratoires Trianon Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 5, 2021 | RIVASA 81 MG EC | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 5, 2021 | AURO-CLOPIDOGREL | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 5, 2021 | VORICONAZOLE FOR INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 5, 2021 | SARCLISA | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 5, 2021 | EXTRA STRENGTH IBUPROFEN LIQUID GEL CAPSULES; IBUPROFEN LIQUID GEL CAPSULES | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 4, 2021 | OPDIVO | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| May 4, 2021 | APO-AMOXICILLIN-CLAVULANATE | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 4, 2021 | MED-ROSUVASTATIN | Generic Medical Partners Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 4, 2021 | MAR-RANITIDINE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 3, 2021 | SUFENTANIL CITRATE INJECTION | Telip, Llc, A Subsidiary Of Teligent, Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 3, 2021 | TARO-FINGOLIMOD | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 3, 2021 | BOOSTRIX-POLIO | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 3, 2021 | INFANRIX HEXA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 3, 2021 | INFANRIX-IPV/HIB | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 3, 2021 | INFANRIX-IPV | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 3, 2021 | SANDOZ PIRFENIDONE CAPSULES | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 3, 2021 | SANDOZ PIRFENIDONE TABLETS | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 3, 2021 | SANDOZ PIRFENIDONE CAPSULES | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 3, 2021 | SANDOZ PIRFENIDONE TABLETS | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 3, 2021 | TEVA-PANTOPRAZOLE MAGNESIUM | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 3, 2021 | ERTAPENEM FOR INJECTION | Hikma Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 3, 2021 | APO-DARUNAVIR | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 3, 2021 | UPTRAVI | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 3, 2021 | SOLIQUA | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 30, 2021 | ANTITHROMBIN III NF (AT III NF) | Takeda Canada Incorporated | New Drug Submission (NDS) · Labelling Only |
| April 30, 2021 | OLMETEC | Organon Canada Inc. | New Drug Submission (NDS) · Admin |
| April 30, 2021 | ELOCOM | Organon Canada Inc. | New Drug Submission (NDS) · Admin |
| April 30, 2021 | BUSPIRONE-10; BUSPIRONE-5 | Pro Doc Limitee | Supplement to a New Drug Submission (SNDS) · Admin |
| April 30, 2021 | ZEVTERA | Avir Pharma Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 30, 2021 | RASILEZ | Noden Pharma Dac | Supplement to a New Drug Submission (SNDS) · Other |
| April 30, 2021 | ACH-FLUOXETINE | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 30, 2021 | OPDIVO | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| April 30, 2021 | INPROSUB | Ibsa Institut Biochimique Sa | New Drug Submission (NDS) · Other |
| April 30, 2021 | AURO-CARVEDILOL | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 29, 2021 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 29, 2021 | AG-ZOPICLONE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 29, 2021 | IBUPROFEN ORAL SUSPENSION USP | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 29, 2021 | NAPROXEN SODIUM TABLETS | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 29, 2021 | VYXEOS | Jazz Pharmaceuticals Ireland Limited | New Drug Submission (NDS) · Priority |
| April 29, 2021 | LEMTRADA | Sanofi Genzyme, A Division Of Sanofi-Aventis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 29, 2021 | PEMETREXED FOR INJECTION | Accord Healthcare Inc | Abbreviated New Drug Submission (ANDS) · Other |
| April 28, 2021 | ROTARIX | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 28, 2021 | EZETROL | Organon Canada Inc. | New Drug Submission (NDS) · Admin |
| April 28, 2021 | SAPHRIS | Organon Canada Inc. | New Drug Submission (NDS) · Admin |
| April 28, 2021 | RIVA-TENOFOVIR | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| April 28, 2021 | BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION | Teligent Canada Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| April 28, 2021 | MAR-ABIRATERONE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 28, 2021 | OLMETEC PLUS | Organon Canada Inc. | New Drug Submission (NDS) · Admin |
| April 28, 2021 | OLANZAPINE ODT | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 28, 2021 | GD-AMLODIPINE/ATORVASTATIN | Upjohn Canada Ulc | Supplement to a New Drug Submission (SNDS) · Admin |
| April 28, 2021 | ZOPICLONE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 28, 2021 | PRO-ZOPICLONE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 28, 2021 | TARO-CAPECITABINE | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 28, 2021 | PONVORY | Janssen Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| April 28, 2021 | PHARMASIN 40 | Huvepharma Eood | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 27, 2021 | POLIVY | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 26, 2021 | PROMETRIUM | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 23, 2021 | AJOVY | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 23, 2021 | TEVA-SERTRALINE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 23, 2021 | ZENHALE | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 23, 2021 | MAR-FINGOLIMOD | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 23, 2021 | SANDOZ PRAVASTATIN TABLETS | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 23, 2021 | SANDOZ LISINOPRIL HCT | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 23, 2021 | JAMP-MYCOPHENOLATE CAPSULES | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| April 23, 2021 | KAZANO | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| April 23, 2021 | NESINA | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| April 22, 2021 | REPATHA | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 22, 2021 | SINEMET | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 22, 2021 | REACTINE FAST MELT JUNIOR | McNeil Consumer Healthcare, division of Johnson & Johnson Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 22, 2021 | NAPROXEN SODIUM CAPSULES | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 22, 2021 | JAMP-ZOPICLONE TABLETS | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 22, 2021 | MAR-TRAMADOL | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 22, 2021 | RIVA-BRIMONIDINE | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| April 22, 2021 | SANDOSTATIN; SANDOSTATIN LAR | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 22, 2021 | MINT-EPLERENONE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 22, 2021 | NALOXONE HYDROCHLORIDE INJECTION, USP | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| April 22, 2021 | SEROQUEL; SEROQUEL XR | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 22, 2021 | TRIFERIC AVNU | Rockwell Medical Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| April 22, 2021 | NEXGARD SPECTRA | Boehringer Ingelheim Animal Health Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 21, 2021 | NAGLAZYME | Biomarin Pharmaceutical Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 21, 2021 | DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP 28; DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP 21 | Glenmark Pharmaceuticals Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 21, 2021 | ASMANEX TWISTHALER | Organon Canada Inc. | New Drug Submission (NDS) · Admin |
| April 21, 2021 | APO-ESOMEPRAZOLE | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| April 21, 2021 | JAMP HYDROXYCHLOROQUINE SULFATE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 21, 2021 | ENSPRYNG | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 21, 2021 | HUMIRA | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| April 21, 2021 | MINT-PIOGLITAZONE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 21, 2021 | CYTARABINE INJECTION | Sterimax Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| April 21, 2021 | TEVA-TICAGRELOR | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| April 21, 2021 | LOTRIDERM | Organon Canada Inc. | New Drug Submission (NDS) · Admin |
| April 21, 2021 | PROPECIA | Organon Canada Inc. | New Drug Submission (NDS) · Admin |
| April 21, 2021 | PROSCAR | Organon Canada Inc. | New Drug Submission (NDS) · Admin |
| April 21, 2021 | PHARMA-LEVETIRACETAM | Pharmascience Inc. | New Drug Submission (NDS) · Admin |
| April 21, 2021 | TEVA-TICAGRELOR | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 21, 2021 | MED-DORZOLAMIDE-TIMOLOL | Generic Medical Partners Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 21, 2021 | PROGRAM 40; PROGRAM 80 | Elanco Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 20, 2021 | WAYMADE-TRIENTINE | Waymade Plc | New Drug Submission (NDS) · New Active Substance (NAS) |
| April 20, 2021 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 20, 2021 | AVAPRO | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 20, 2021 | XELODA | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 20, 2021 | MINT-ONDANSETRON | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 20, 2021 | CELESTONE SOLUSPAN | Organon Canada Inc. | New Drug Submission (NDS) · Admin |
| April 20, 2021 | BETEFLAM | Ibsa Institut Biochimique Sa | New Drug Submission (NDS) · Admin |
| April 20, 2021 | MINT-PREGABALIN | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| April 20, 2021 | SOJOURN SEVOFLURANE | Piramal Critical Care, Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 19, 2021 | OLIMEL 3.3% E; OLIMEL 4.4% E; OLIMEL 5.7% E; OLIMEL 7.6% E; PERIOLIMEL 2.5% E | Baxter Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| April 19, 2021 | OLIMEL 4.4%; OLIMEL 5.7%; OLIMEL 7.6% | Baxter Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| April 19, 2021 | ACH-FINGOLIMOD | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 16, 2021 | HERZUMA | Celltrion Healthcare Co Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| April 16, 2021 | VOSEVI | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 16, 2021 | DIPROSALIC | Organon Canada Inc. | New Drug Submission (NDS) · Admin |
| April 16, 2021 | MYLAN-TOPIRAMATE | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 16, 2021 | OPSUMIT | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 16, 2021 | AVALIDE | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 16, 2021 | TARO-CLOTRIMAZOLE/BETAMETHASONE DIPROPIONATE | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| April 16, 2021 | FENOFIBRATE | Apotex Inc. | New Drug Submission (NDS) · Labelling Only |
| April 16, 2021 | JAMP MONTELUKAST CHEWABLE TABLETS | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| April 15, 2021 | ENHERTU | Astrazeneca Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| April 15, 2021 | SANDOZ TELMISARTAN HCT | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 15, 2021 | MYLAN-FLUCONAZOLE | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 15, 2021 | ACTEMRA | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 15, 2021 | FUROSEMIDE | Sanis Health Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| April 15, 2021 | AA-TELMISARTAN-AMLODIPINE | AA Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 15, 2021 | ACH-ATORVASTATIN CALCIUM | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| April 15, 2021 | PANTOPRAZOLE | Ranbaxy Pharmaceuticals Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| April 15, 2021 | PMS-LOXAPINE | Pharmascience Inc. | New Drug Submission (NDS) · Admin |
| April 15, 2021 | NEXPLANON | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 15, 2021 | ROCURONIUM BROMIDE INJECTION | Pfizer Canada Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 14, 2021 | TRAZIMERA | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| April 14, 2021 | EVRYSDI | Hoffmann-La Roche Limited | New Drug Submission (NDS) · Priority-NAS |
| April 14, 2021 | ZONOVATE | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 14, 2021 | KANJINTI | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 14, 2021 | LUCENTIS | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 14, 2021 | PROHANCE | Bracco Imaging Canada | Supplement to a New Drug Submission (SNDS) · Other |
| April 14, 2021 | JAMP DILTIAZEM T | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 14, 2021 | VASERETIC | Organon Canada Inc. | New Drug Submission (NDS) · Admin |
| April 14, 2021 | LEVETIRACETAM | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 14, 2021 | DIPROLENE | Organon Canada Inc. | New Drug Submission (NDS) · Admin |
| April 14, 2021 | CAPECITABINE | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| April 14, 2021 | DENAGARD 12.5% | Elanco Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 14, 2021 | DENAGARD 10% GF PREMIX | Elanco Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 14, 2021 | CLOTRIMAZOLE EXTRA STRENGTH EXTERNAL ANTIFUNGAL CREAM | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 14, 2021 | TOPOTECAN HYDROCHLORIDE FOR INJECTION | Pfizer Canada Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 14, 2021 | TARO-DOCETAXEL | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 14, 2021 | MAR-ONDANSETRON ODT | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| April 13, 2021 | SANDOZ LEVETIRACETAM | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 13, 2021 | SIMPARICA | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 13, 2021 | SUBLOCADE | Indivior Uk Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 13, 2021 | APO-AMOXICILLIN | Apotex Inc. | New Drug Submission (NDS) · Labelling Only |
| April 13, 2021 | SANDOZ BISOPROLOL TABLETS | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 13, 2021 | DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP | Glenmark Pharmaceuticals Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 13, 2021 | BRYHALI | Bausch Health, Canada Inc. | New Drug Submission (NDS) · Labelling Only |
| April 13, 2021 | TRESADERM | Boehringer Ingelheim Animal Health Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 13, 2021 | 20% PROSOL | Baxter Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| April 13, 2021 | TEVA-ATAZANAVIR | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 13, 2021 | VASOTEC | Organon Canada Inc. | New Drug Submission (NDS) · Admin |
| April 12, 2021 | OPDIVO | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| April 12, 2021 | ONDANSETRON INJECTION USP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 12, 2021 | DARZALEX SC | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 12, 2021 | PRIVA-ZOPICLONE | Pharmapar Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 12, 2021 | APO-HYDROMORPHONE CR | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| April 9, 2021 | GAMMAGARD S/D | Takeda Canada Incorporated | New Drug Submission (NDS) · Labelling Only |
| April 9, 2021 | ITULATEK | Alk-Abello Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 9, 2021 | DIPROSONE | Organon Canada Inc. | New Drug Submission (NDS) · Admin |
| April 9, 2021 | AG-RASAGILINE | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| April 9, 2021 | TEVA-DASATINIB | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 9, 2021 | ETODOLAC | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| April 9, 2021 | APO-DOXYCYCLINE MR | Apotex Inc. | New Drug Submission (NDS) · Labelling Only |
| April 9, 2021 | IBSRELA | Knight Therapeutics Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 9, 2021 | MITOMYCIN FOR INJECTION | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 9, 2021 | HYDROMORPHONE HYDROCHLORIDE INJECTION USP | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 9, 2021 | HYZAAR; HYZAAR DS | Organon Canada Inc. | New Drug Submission (NDS) · Admin |
| April 9, 2021 | AMLODIPINE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 9, 2021 | NAPROXEN CAPSULES 200 MG | Catalent Ontario Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 9, 2021 | CARIPUL | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 9, 2021 | REDDY-DASATINIB | Dr Reddys Laboratories Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| April 8, 2021 | PRIVA-CELECOXIB | Pharmapar Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 8, 2021 | PREGABALIN | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| April 8, 2021 | ZOCOR | Organon Canada Inc. | New Drug Submission (NDS) · Admin |
| April 8, 2021 | COZAAR | Organon Canada Inc. | New Drug Submission (NDS) · Admin |
| April 8, 2021 | TRAZODONE | Sanis Health Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| April 8, 2021 | DILTIAZEM TZ | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 8, 2021 | ACH-MONTELUKAST | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| April 8, 2021 | PERIOSTAT | Pendopharm Division Of Pharmascience Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 8, 2021 | MINT-ATENOL | Mint Pharmaceuticals Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 8, 2021 | SULFATRIM; SULFATRIM DS; SULFATRIM PEDIATRIC | AA Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 8, 2021 | REVOLADE | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 8, 2021 | APO-ABIRATERONE FILM COATED TABLETS | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 8, 2021 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | Telip, Llc | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| April 8, 2021 | PMS-OXYCODONE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 8, 2021 | GD-SIROLIMUS | Genmed A Division Of Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| April 8, 2021 | OVAGEN | Icpbio Reproduction | Supplement to a New Drug Submission (SNDS) · Other |
| April 7, 2021 | TRULICITY | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 7, 2021 | MINT-LEVETIRACETAM | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 7, 2021 | ONDANSETRON | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 7, 2021 | KETOCONAZOLE | Apotex Inc. | New Drug Submission (NDS) · Labelling Only |
| April 7, 2021 | MINT-TRAMADOL/ACET | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 7, 2021 | VITRECTO | Intervet Canada Corp | Supplement to a New Drug Submission (SNDS) · Other |
| April 6, 2021 | NORTRIPTYLINE | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| April 6, 2021 | VISUDYNE | Cheplapharm Arzneimittel Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| April 6, 2021 | AA-ADEFOVIR | AA Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| April 6, 2021 | GABAPENTIN | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 6, 2021 | CELECOXIB | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 6, 2021 | MONTELUKAST | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 6, 2021 | SINEMET | Organon Canada Inc. | New Drug Submission (NDS) · Admin |
| April 1, 2021 | NUWIQ | Octapharma Pharmazeutika Produktionsges M B H | Supplement to a New Drug Submission (SNDS) · Other |
| April 1, 2021 | REMICADE | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 1, 2021 | OCREVUS | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 1, 2021 | IRESSA | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 1, 2021 | AURO-LEVETIRACETAM | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 1, 2021 | DOCETAXEL INJECTION USP | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| April 1, 2021 | ZOLEDRONIC ACID CONCENTRATE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 1, 2021 | DUODOPA | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| April 1, 2021 | TEVA-VARENICLINE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 1, 2021 | JAMP QUETIAPINE FUMARATE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 1, 2021 | TALTZ | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 31, 2021 | METOPROLOL-L | Sivem Pharmaceuticals Ulc | New Drug Submission (NDS) · Admin |
| March 31, 2021 | ALVESCO | Covis Pharma Gmbh | New Drug Submission (NDS) · Admin |
| March 31, 2021 | CYCLOSPORINE CAPSULES | Strides Pharma Canada Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 31, 2021 | BUSCOPAN | Sanofi Consumer Health Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 31, 2021 | TARO-MOMETASONE CREAM; TARO-MOMETASONE LOTION; TARO-MOMETASONE OINTMENT | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 31, 2021 | PMS-METHADONE | Paladin Labs Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 31, 2021 | METFORMIN TABLETS | Granules India Limited | Abbreviated New Drug Submission (ANDS) · Other |
| March 31, 2021 | EXTRA STRENGTH IBUPROFEN LIQUID CAPSULES | Vita Health Products Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 31, 2021 | COLD + SINUS PLUS | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 30, 2021 | COMPONENT TE-G IMPLANTS WITH TYLAN | Elanco Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 30, 2021 | APO-LEVETIRACETAM | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 30, 2021 | PMS-ABIRATERONE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 30, 2021 | ZENHALE | Organon Canada Inc. | New Drug Submission (NDS) · Admin |
| March 30, 2021 | PROMETRIUM | Organon Canada Inc. | New Drug Submission (NDS) · Admin |
| March 30, 2021 | ORGALUTRAN | Organon Canada Inc. | New Drug Submission (NDS) · Admin |
| March 30, 2021 | AURO-TRAMADOL | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 30, 2021 | SANDOZ ABIRATERONE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 30, 2021 | M-LATANOPROST-TIMOLOL | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 30, 2021 | COMPONENT TE-H IMPLANTS WITH TYLAN | Elanco Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 30, 2021 | COMPONENT TE-200 IMPLANTS WITH TYLAN | Elanco Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 30, 2021 | COMPONENT TE-100 IMPLANTS WITH TYLAN | Elanco Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 30, 2021 | COMPONENT TE-S IMPLANTS WITH TYLAN | Elanco Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 30, 2021 | IMFINZI | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 30, 2021 | HAEGARDA | Csl Behring Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 30, 2021 | BRAFTOVI | Pfizer Canada Ulc | New Drug Submission (NDS) · Other |
| March 29, 2021 | PRO-LEVETIRACETAM - 250; PRO-LEVETIRACETAM - 500; PRO-LEVETIRACETAM - 750 | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 29, 2021 | LANSOPRAZOLE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 29, 2021 | PRO-AMOX-125; PRO-AMOX-250 | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 29, 2021 | LANSOPRAZOLE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 29, 2021 | PROFENDER | Vetoquinol N A Inc | New Drug Submission (NDS) · Admin |
| March 29, 2021 | PROFENDER | Vetoquinol N A Inc | New Drug Submission (NDS) · Admin |
| March 29, 2021 | PROFENDER | Vetoquinol N A Inc | New Drug Submission (NDS) · Admin |
| March 29, 2021 | SEPTRA INJECTION | Aspen Pharmacare Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 29, 2021 | BENZACLIN | Bausch Health, Canada Inc. | New Drug Submission (NDS) · Labelling Only |
| March 29, 2021 | THALOMID | Celgene Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 29, 2021 | ACH-BICALUTAMIDE | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 29, 2021 | SANDOZ TELMISARTAN HCT | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 29, 2021 | ASN-DRONEDARONE | Ascend Laboratories Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| March 26, 2021 | VENLAFAXINE XR | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 26, 2021 | BALVERSA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 26, 2021 | PUREGON | Organon Canada Inc. | New Drug Submission (NDS) · Admin |
| March 26, 2021 | AMOXICILLIN | Sivem Pharmaceuticals Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 26, 2021 | CABENUVA; VOCABRIA | Viiv Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 26, 2021 | DULOXETINE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 26, 2021 | ESOMEPRAZOLE | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| March 26, 2021 | NUVARING | Organon Canada Inc. | New Drug Submission (NDS) · Admin |
| March 26, 2021 | HUMALOG; HUMALOG 200 UNITS/ML KWIKPEN; HUMALOG MIX 25 AND MIX 50 | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 26, 2021 | BASAGLAR | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 26, 2021 | HUMULIN 30/70; HUMULIN N; HUMULIN R | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 26, 2021 | ENTUZITY | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 26, 2021 | PDP-DESONIDE | Pendopharm Division Of Pharmascience Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 26, 2021 | TECENTRIQ | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 26, 2021 | ACETYLCYSTEINE SOLUTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 26, 2021 | CYMBALTA | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 26, 2021 | RADICAVA | Mitsubishi Tanabe Pharma Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| March 26, 2021 | SANDOZ METHYLPHENIDATE SR | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 25, 2021 | ALENDRONATE | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| March 25, 2021 | VISTASEAL | Instituto Grifols S.A. | New Drug Submission (NDS) · Other |
| March 25, 2021 | SOLIRIS | Alexion Pharma Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| March 25, 2021 | LYNPARZA | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 25, 2021 | SOMATULINE AUTOGEL | Ipsen Biopharmaceuticals Canada Inc | New Drug Submission (NDS) · Labelling Only |
| March 25, 2021 | CIPROFLOXACIN | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 25, 2021 | MEROPENEM FOR INJECTION, USP | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 25, 2021 | AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 25, 2021 | CHILDREN'S ADVIL | Glaxosmithkline Consumer Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 24, 2021 | MIRTAZAPINE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 24, 2021 | MARVELON 21; MARVELON 28 | Organon Canada Inc. | New Drug Submission (NDS) · Admin |
| March 24, 2021 | CABLIVI | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 24, 2021 | TARO-DASATINIB | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 24, 2021 | MUSCLE & JOINT | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 24, 2021 | DUPIXENT | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 24, 2021 | MINT-ENTECAVIR | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 23, 2021 | AIMOVIG | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 23, 2021 | TARO-CELECOXIB | Sun Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 23, 2021 | SANDOZ AMPHETAMINE XR | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| March 23, 2021 | NEXPLANON | Organon Canada Inc. | New Drug Submission (NDS) · Admin |
| March 23, 2021 | POLYFLEX | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| March 23, 2021 | CEFA-LAK | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| March 23, 2021 | DOBUTAMINE INJECTION USP | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 23, 2021 | MINT-AMLODIPINE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 23, 2021 | MINT-EZETIMIBE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| March 23, 2021 | TRI-CIRA LO 21; TRI-CIRA LO 28 | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| March 22, 2021 | LIPRELOG | Eli Lilly Canada Inc | New Drug Submission (NDS) · Labelling Only |
| March 22, 2021 | TAKHZYRO | Takeda Canada Incorporated | New Drug Submission (NDS) · Admin |
| March 22, 2021 | IMOVAX RABIES | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 22, 2021 | SANDOZ VALACYCLOVIR | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 22, 2021 | ZIEXTENZO | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 22, 2021 | TEVA-BUPRENORPHINE/NALOXONE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| March 22, 2021 | OPDIVO | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| March 22, 2021 | GLN-URSODIOL | Glenmark Pharmaceuticals Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 22, 2021 | SANDOZ TRAMADOL | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 22, 2021 | TRULANCE | Bausch Health, Canada Inc. | New Drug Submission (NDS) · Admin |
| March 22, 2021 | CLARITHROMYCIN | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 22, 2021 | SELEGILINE | AA Pharma Inc. | New Drug Submission (NDS) · Admin |
| March 22, 2021 | ESTROGEL | Organon Canada Inc. | New Drug Submission (NDS) · Admin |
| March 22, 2021 | OCTOSTIM | Ferring Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 22, 2021 | APO-TICAGRELOR | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 22, 2021 | APO-TICAGRELOR | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 22, 2021 | RESPOTIL | Modern Veterinary Therapeutics Llc | Abbreviated New Drug Submission (ANDS) · Other |
| March 22, 2021 | DILTIAZEM HYDROCHLORIDE INJECTION | Omega Laboratories Limited | Abbreviated New Drug Submission (ANDS) · Other |
| March 22, 2021 | APO-TICAGRELOR | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 19, 2021 | ENBREL | Immunex Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| March 19, 2021 | MEKINIST | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 19, 2021 | TAFINLAR | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 19, 2021 | ASACOL 800 | Allergan Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 19, 2021 | ASACOL | Allergan Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 19, 2021 | APO-MYCOPHENOLATE MOFETIL | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| March 19, 2021 | HUMIRA | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| March 19, 2021 | KIT FOR THE PREPARATION OF TECHNETIUM (99MTC) PYROPHOSPHATE INJECTION | Isologic Innovative Radiopharmaceuticals Ltd. | Abbreviated New Drug Submission (ANDS) · Other |
| March 19, 2021 | GLYCOPYRROLATE INJECTION USP | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| March 19, 2021 | TEVA-PREGABALIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 19, 2021 | M-ESCITALOPRAM | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| March 19, 2021 | TIVICAY | Viiv Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 19, 2021 | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USP | Baxter Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| March 18, 2021 | GAMMAGARD LIQUID | Takeda Canada Incorporated | New Drug Submission (NDS) · Labelling Only |
| March 18, 2021 | APO-ESCITALOPRAM | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 18, 2021 | MAVIRET | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| March 18, 2021 | ZEPATIER | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 18, 2021 | TARO-AMPHETAMINE XR | Sun Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 18, 2021 | GEMCITABINE INJECTION | Pfizer Canada Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 18, 2021 | DESMOPRESSIN SPRAY | AA Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 17, 2021 | M-M-R II | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 17, 2021 | INVANZ | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 17, 2021 | DARZALEX; DARZALEX SC | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 17, 2021 | ACH-QUETIAPINE FUMARATE XR | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 17, 2021 | GLYXAMBI | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| March 17, 2021 | REBINYN | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 17, 2021 | APO-BECLOMETHASONE NASAL SPRAY | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 17, 2021 | BAQSIMI | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 17, 2021 | SANDOZ MORPHINE SR | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 17, 2021 | APO-PRAMIPEXOLE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 16, 2021 | JORVEZA | Avir Pharma Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 16, 2021 | APO-ZOPICLONE | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 16, 2021 | JAMP-VARDENAFIL ODT | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 16, 2021 | MED-DORZOLAMIDE | Generic Medical Partners Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 16, 2021 | VENTOLIN HFA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 16, 2021 | JENTADUETO | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| March 16, 2021 | DEPO-PROVERA | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 16, 2021 | DEPO-MEDROL WITH LIDOCAINE | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 15, 2021 | AG-CITALOPRAM TABLETS | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| March 15, 2021 | ONDISSOLVE ODF | Takeda Canada Incorporated | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 12, 2021 | PRO-AMOX-250; PRO-AMOX-500 | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 12, 2021 | PRO-FLUCONAZOLE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 12, 2021 | BUPROPION SR | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 12, 2021 | PRO-TOPIRAMATE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 12, 2021 | ARIPIPRAZOLE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 12, 2021 | PRO-MIRTAZAPINE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 12, 2021 | VENLAFAXINE XR | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 12, 2021 | MYLAN-PROPAFENONE | Mylan Pharmaceuticals Ulc | Supplement to a New Drug Submission (SNDS) · Admin |
| March 12, 2021 | BACLOFEN-10; BACLOFEN-20 | Pro Doc Limitee | Supplement to a New Drug Submission (SNDS) · Admin |
| March 12, 2021 | GLUCAGEN; GLUCAGEN HYPOKIT | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 12, 2021 | RIXUBIS | Takeda Canada Incorporated | New Drug Submission (NDS) · Labelling Only |
| March 12, 2021 | PINAVERIUM | AA Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 12, 2021 | SOLU-MEDROL; SOLU-MEDROL ACT-O-VIALS | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 12, 2021 | RAN-OXYCODONE CR | Ranbaxy Pharmaceuticals Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 12, 2021 | ONBREZ BREEZHALER | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 12, 2021 | GLATECT | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 12, 2021 | REDDY-VALSARTAN | Dr Reddys Laboratories Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| March 12, 2021 | BIPAZEN | Kvr Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 11, 2021 | TRAZIMERA | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 11, 2021 | HULIO | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| March 11, 2021 | RIABNI | Amgen Canada Inc | New Drug Submission (NDS) · Other |
| March 11, 2021 | BOTOX | Allergan Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 11, 2021 | NEUPRO | Ucb Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 11, 2021 | ONPATTRO | Alnylam Netherlands B.V. | Supplement to a New Drug Submission (SNDS) · Other |
| March 11, 2021 | TRINTELLIX | Lundbeck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 11, 2021 | ARSENIC TRIOXIDE FOR INJECTION | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 10, 2021 | MENOPUR | Ferring Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 10, 2021 | ZOLPIDEM TARTRATE ODT | Bausch Health, Canada Inc. | New Drug Submission (NDS) · Admin |
| March 10, 2021 | CLONAPAM | Bausch Health, Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 10, 2021 | WELLBUTRIN SR | Bausch Health, Canada Inc. | New Drug Submission (NDS) · Admin |
| March 10, 2021 | SANDOZ PERINDOPRIL ERBUMINE/INDAPAMIDE; SANDOZ PERINDOPRIL ERBUMINE/INDAPAMIDE HD; SANDOZ PERINDOPRIL ERBUMINE/INDAPAMIDE LD | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 10, 2021 | OXYBUTYNIN; OXYBUTYNIN SYRUP | Apotex Inc. | New Drug Submission (NDS) · Labelling Only |
| March 10, 2021 | BENEFIX | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 9, 2021 | DARZALEX | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 9, 2021 | SANDOZ PANTOPRAZOLE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 9, 2021 | ZOLMITRIPTAN; ZOLMITRIPTAN ODT | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 9, 2021 | CEFAZOLIN FOR INJECTION USP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 9, 2021 | MYLAN-EFAVIRENZ | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 9, 2021 | PMS-PANTOPRAZOLE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 9, 2021 | CEFADROXIL | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 9, 2021 | M-LATANOPROST | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 9, 2021 | NARCAN NASAL SPRAY | Emergent Operations Ireland Limited | New Drug Submission (NDS) · Admin |
| March 9, 2021 | FUROSEMIDE INJECTION, USP | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 8, 2021 | CELECOXIB | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 8, 2021 | RIVA-CELECOX | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 8, 2021 | BIO-CELECOXIB | Biomed Pharma | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 8, 2021 | CEFAZOLIN FOR INJECTION | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 8, 2021 | SEREVENT DISKUS | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 8, 2021 | NOLVADEX-D | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 8, 2021 | PDP-AMLODIPINE | Pendopharm Division Of Pharmascience Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 8, 2021 | FLUCELVAX QUAD | Seqirus Uk Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 8, 2021 | TEVA-SAXAGLIPTIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 8, 2021 | APO-LAMIVUDINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 8, 2021 | METFORMIN | Apotex Inc. | New Drug Submission (NDS) · Labelling Only |
| March 8, 2021 | PREVACID; PREVACID FASTAB | Takeda Pharmaceuticals America Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 8, 2021 | BUSPIRONE HYDROCHLORIDE TABLETS, USP | Strides Pharma Canada Inc | Abbreviated New Drug Submission (ANDS) · Other |
| March 8, 2021 | APO-SAXAGLIPTIN | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 8, 2021 | SANDOZ SAXAGLIPTIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| March 8, 2021 | SANDOZ SAXAGLIPTIN | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 8, 2021 | TEVA-SAXAGLIPTIN | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| March 5, 2021 | YERVOY | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| March 5, 2021 | SANDOZ PRAMIPEXOLE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 5, 2021 | SANDOZ TELMISARTAN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 5, 2021 | NAT-CETIRIZINE | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 5, 2021 | IMBRUVICA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 5, 2021 | TECENTRIQ | Hoffmann-La Roche Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 5, 2021 | IPG-PAROXETINE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 5, 2021 | MYLAN-LANSOPRAZOLE; MYLAN-LANSOPRAZOLE FDT | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 5, 2021 | ASA | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 5, 2021 | NIGHTTIME PAIN RELIEF | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 5, 2021 | BELSOMRA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 5, 2021 | PMS-FINASTERIDE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 5, 2021 | ACH-TELMISARTAN | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 5, 2021 | HYDROMORPHONE HYDROCHLORIDE INJECTION, USP | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 5, 2021 | FLOVENT DISKUS; FLOVENT HFA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 5, 2021 | DEPO-MEDROL; DEPO-MEDROL (WITH PRESERVATIVE) | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 5, 2021 | VIIBRYD | Allergan Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 5, 2021 | NEXTSTELLIS | Searchlight Pharma Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| March 4, 2021 | M-ZOPICLONE | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 4, 2021 | PRAVASTATIN-10; PRAVASTATIN-20; PRAVASTATIN-40 | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 4, 2021 | MYLAN-LAMOTRIGINE | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 4, 2021 | TEVA-FINGOLIMOD | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 4, 2021 | QUETIAPINE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 4, 2021 | BIO-ZOPICLONE | Biomed Pharma | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 4, 2021 | CLINDA-T | Bausch Health, Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 4, 2021 | APO-VORICONAZOLE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 4, 2021 | JAMP-METOPROLOL-L | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 4, 2021 | AURO-DARUNAVIR | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 4, 2021 | TEVA-AZATHIOPRINE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 4, 2021 | ASN-CEPHALEXIN | Ascend Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 4, 2021 | APO-PROPAFENONE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 4, 2021 | MINT-AMOXI/CLAV | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| March 4, 2021 | ALDACTAZIDE 25; ALDACTAZIDE 50 | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 4, 2021 | TEVA-CLOPIDOGREL | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 4, 2021 | TEVA-SERTRALINE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 4, 2021 | MINT-OLOPATADINE 0.2% | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| March 4, 2021 | JAMP ATAZANAVIR | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| March 3, 2021 | ALUNBRIG | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| March 3, 2021 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 3, 2021 | ACCURETIC | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 3, 2021 | IMIQUIMOD | Bausch Health, Canada Inc. | New Drug Submission (NDS) · Admin |
| March 3, 2021 | ALTACE HCT | Bausch Health, Canada Inc. | New Drug Submission (NDS) · Admin |
| March 3, 2021 | TAMBOCOR | Bausch Health, Canada Inc. | New Drug Submission (NDS) · Admin |
| March 3, 2021 | TEVA-CYCLOSPORINE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 3, 2021 | TEVA-METOPROLOL; TEVA-METOPROLOL (FILM COATED) | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 3, 2021 | MINT-CETIRIZINE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 3, 2021 | ABILIFY MAINTENA | Otsuka Pharmaceutical Co Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| March 2, 2021 | PRO-QUETIAPINE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 2, 2021 | AMLODIPINE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 2, 2021 | IRINOTECAN | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Admin |
| March 2, 2021 | MEKTOVI | Pfizer Canada Ulc | New Drug Submission (NDS) · New Active Substance (NAS) |
| March 2, 2021 | NAT-ONDANSETRON | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 2, 2021 | TEVA-ABIRATERONE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 2, 2021 | VEKLURY | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 2, 2021 | BRAFTOVI | Pfizer Canada Ulc | New Drug Submission (NDS) · New Active Substance (NAS) |
| March 2, 2021 | TEVA-ABIRATERONE | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| March 2, 2021 | CELLCEPT | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 2, 2021 | PMS-FINASTERIDE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| March 1, 2021 | METACAM ORAL SUSPENSION FOR CATS | Boehringer Ingelheim Animal Health Canada Inc. | New Drug Submission (NDS) · Admin |
| March 1, 2021 | ACH-METFORMIN | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 1, 2021 | PHESGO | Hoffmann-La Roche Limited | New Drug Submission (NDS) · Other |
| March 1, 2021 | TECENTRIQ | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 1, 2021 | TARO-TICAGRELOR | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 1, 2021 | GPC-METFORMIN XR | Strides Pharma Canada Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 1, 2021 | METACAM 0.5% INJECTION | Boehringer Ingelheim Animal Health Canada Inc. | New Drug Submission (NDS) · Admin |
| March 1, 2021 | TEVA-TAMSULOSIN CR | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 1, 2021 | BRUKINSA | Beigene Switzerland Gmbh | New Drug Submission (NDS) · Priority-NAS |
| March 1, 2021 | OPDIVO | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| March 1, 2021 | GPC-METFORMIN XR | Strides Pharma Canada Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| March 1, 2021 | SANDOZ METFORMIN XR | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| March 1, 2021 | TARO-TICAGRELOR | Taro Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| March 1, 2021 | GPC-METFORMIN XR | Generic Partners (Canada) Inc | Abbreviated New Drug Submission (ANDS) · Other |
| February 28, 2021 | AURO-PAROXETINE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 26, 2021 | MOTRIN LIQUID GELS 200 MG; MOTRIN LIQUID GELS 400 MG | McNeil Consumer Healthcare, division of Johnson & Johnson Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 26, 2021 | TRAJENTA | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| February 26, 2021 | LOVASTATIN | AA Pharma Inc. | New Drug Submission (NDS) · Admin |
| February 26, 2021 | PHENYTOIN SODIUM | AA Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 26, 2021 | PENLAC | Bausch Health, Canada Inc. | New Drug Submission (NDS) · Admin |
| February 26, 2021 | TEVA-CITALOPRAM | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| February 26, 2021 | TOMUDEX | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 26, 2021 | METADOL-D | Paladin Labs Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 26, 2021 | METADOL | Paladin Labs Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 25, 2021 | PULMOZYME | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 25, 2021 | MOXIFLOXACIN | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 25, 2021 | SAXENDA | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 25, 2021 | PERJETA; PERJETA - HERCEPTIN COMBO PACK | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 25, 2021 | MINIPRESS | AA Pharma Inc. | New Drug Submission (NDS) · Admin |
| February 25, 2021 | ROSUVASTATIN | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 25, 2021 | NAT-DONEPEZIL | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 25, 2021 | BIO-ZOLMITRIPTAN | Biomed Pharma | Abbreviated New Drug Submission (ANDS) · Admin |
| February 25, 2021 | CHLORHEXIDINE | Bajaj Medical, Llc | Abbreviated New Drug Submission (ANDS) · Admin |
| February 25, 2021 | TEVA-LEVOCARBIDOPA | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 25, 2021 | TEVETEN PLUS | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| February 25, 2021 | CEFTRIAXONE SODIUM FOR INJECTION BP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 25, 2021 | ACCEL-RIZATRIPTAN ODT | Accel Pharma Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 25, 2021 | LACOSAMIDE | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| February 25, 2021 | SALOFALK | Aptalis Pharma Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 25, 2021 | AA-LEVOCARB CR | AA Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 25, 2021 | REVATIO | Upjohn Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 25, 2021 | MINT-TENOFOVIR | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| February 25, 2021 | BENDAMUSTINE HYDROCHLORIDE FOR INJECTION | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| February 25, 2021 | BENDAMUSTINE HYDROCHLORIDE FOR INJECTION | Mylan Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Other |
| February 25, 2021 | BENDAMUSTINE HYDROCHLORIDE FOR INJECTION | Accord Healthcare Inc | Abbreviated New Drug Submission (ANDS) · Other |
| February 25, 2021 | BENDAMUSTINE HYDROCHLORIDE FOR INJECTION | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| February 24, 2021 | ATORVASTATIN-10; ATORVASTATIN-20; ATORVASTATIN-40; ATORVASTATIN-80 | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| February 24, 2021 | CETIRIZINE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 24, 2021 | FINASTERIDE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 24, 2021 | BACITRACIN MD SOLUBLE | Bio Agri Mix Lp | Abbreviated New Drug Submission (ANDS) · Other |
| February 23, 2021 | VISIPAQUE 270; VISIPAQUE 320 | Ge Healthcare Canada Inc | Supplement to a New Drug Submission (SNDS) · Labelling Only |
| February 23, 2021 | PRIVA-ENALAPRIL | Pharmapar Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| February 23, 2021 | BRIDION | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 23, 2021 | PMS-FINGOLIMOD | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 23, 2021 | PMS-LEVETIRACETAM | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 23, 2021 | RIVA-LEVETIRACETAM | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 22, 2021 | CINRYZE | Viropharma Biologics Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 22, 2021 | BACLOFEN INJECTION | Teligent Pharma, Inc . | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| February 22, 2021 | ILARIS | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 22, 2021 | DUPIXENT | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 22, 2021 | MINT-PIOGLITAZONE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 22, 2021 | LIPIDIL EZ | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| February 19, 2021 | INFLECTRA | Celltrion Healthcare Co Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| February 19, 2021 | AFLURIA TETRA | Seqirus Pty Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| February 19, 2021 | REPLAGAL | Takeda Canada Incorporated | New Drug Submission (NDS) · Labelling Only |
| February 19, 2021 | CUVITRU | Takeda Canada Incorporated | New Drug Submission (NDS) · Labelling Only |
| February 19, 2021 | HERCEPTIN | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 19, 2021 | DYSPORT THERAPEUTIC | Ipsen Biopharm Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 19, 2021 | SEASONIQUE | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 19, 2021 | SEASONALE | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 19, 2021 | MEZAVANT | Takeda Canada Incorporated | New Drug Submission (NDS) · Labelling Only |
| February 19, 2021 | PMS-ZOPICLONE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 19, 2021 | APO-AMOXI | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 19, 2021 | MINT-ARIPIPRAZOLE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 19, 2021 | APO-SULFATRIM ORAL SUSPENSION | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 18, 2021 | ACT ONDANSETRON | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 18, 2021 | KETAMINE HYDROCHLORIDE INJECTION USP | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 18, 2021 | IRINOTECAN HYDROCHLORIDE INJECTION | Teligent Pharma, Inc . | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| February 18, 2021 | CLOPIDOGREL | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| February 18, 2021 | ACH-TEMOZOLOMIDE | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 17, 2021 | AMLODIPINE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| February 17, 2021 | DRAXIMAGE DTPA | Jubilant Draximage Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 17, 2021 | GLYCON | Bausch Health, Canada Inc. | New Drug Submission (NDS) · Admin |
| February 17, 2021 | OMNARIS | Covis Pharma Gmbh | New Drug Submission (NDS) · Admin |
| February 17, 2021 | MINT-PRAVASTATIN | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| February 17, 2021 | JAMP DULOXETINE CAPSULES | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| February 17, 2021 | ONDANSETRON INJECTION USP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 17, 2021 | ARIXTRA | Aspen Pharmacare Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 17, 2021 | ACT FLUCONAZOLE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 17, 2021 | APO-AZATHIOPRINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 17, 2021 | EXPERIOR 50 | Elanco Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 17, 2021 | LINCOMYCIN 44 G | Bio Agri Mix Lp | Supplement to a New Drug Submission (SNDS) · Other |
| February 17, 2021 | LINCOMYCIN 110 G | Bio Agri Mix Lp | Supplement to a New Drug Submission (SNDS) · Other |
| February 17, 2021 | TILMOVET AC | Huvepharma Eood | Abbreviated New Drug Submission (ANDS) · Other |
| February 16, 2021 | CEQUA | Sun Pharma Global Fze | New Drug Submission (NDS) · Other |
| February 16, 2021 | ACH-PREGABALIN | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 16, 2021 | SERTRALINE-100; SERTRALINE-25; SERTRALINE-50 | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 16, 2021 | LEMTRADA | Sanofi Genzyme, A Division Of Sanofi-Aventis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 16, 2021 | QUETIAPINE XR | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 16, 2021 | PAROXETINE-10; PAROXETINE-20; PAROXETINE-30 | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 16, 2021 | TARO-MONTELUKAST | Sun Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| February 16, 2021 | TEVA-ABIRATERONE | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| February 16, 2021 | TEVA-ABIRATERONE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 16, 2021 | TASIGNA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 16, 2021 | JAMP LAMIVUDINE HBV | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| February 15, 2021 | POSANOL | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 15, 2021 | DOJOLVI | Ultragenyx Pharmaceutical Inc | New Drug Submission (NDS) · Priority-NAS |
| February 15, 2021 | CEFOTAXIME SODIUM FOR INJECTION, BP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 15, 2021 | MYCOBUTIN | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 12, 2021 | ABILIFY | Otsuka Pharmaceutical Co Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| February 12, 2021 | LEVETIRACETAM | Jubilant Generics Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 12, 2021 | SYMBICORT TURBUHALER | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 12, 2021 | SANDOZ VENLAFAXINE XR | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 12, 2021 | ACYCLOVIR | Apotex Inc. | New Drug Submission (NDS) · Labelling Only |
| February 12, 2021 | ACCEL-HYOSCINE | Accel Pharma Inc | Abbreviated New Drug Submission (ANDS) · Other |
| February 12, 2021 | FUROSEMIDE INJECTION USP | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 12, 2021 | TRINTELLIX | Lundbeck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 12, 2021 | MINT-CITALOPRAM | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 12, 2021 | PMS-VALPROIC ACID; PMS-VALPROIC ACID E.C. | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 12, 2021 | PMS-PREDNISOLONE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 11, 2021 | TRAMADOL/ACETAMINOPHEN | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 11, 2021 | ELAPRASE | Takeda Canada Incorporated | New Drug Submission (NDS) · Other |
| February 11, 2021 | OPDIVO | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| February 11, 2021 | MINT-OLANZAPINE ODT | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 11, 2021 | ROPINIROLE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 11, 2021 | SPUTOLYSIN POWDER | Boehringer Ingelheim Animal Health Canada Inc. | New Drug Submission (NDS) · Admin |
| February 11, 2021 | DIFLUCAN ONE | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 11, 2021 | MINT-FLUOXETINE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 11, 2021 | CLOTRIMAZOLE-FLUCONAZOLE COMBI | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 11, 2021 | BURINEX | Knight Therapeutics Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 11, 2021 | SALOFALK SUPPOSITORIES | Aptalis Pharma Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 11, 2021 | SALOFALK | Aptalis Pharma Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 11, 2021 | CROMOLYN EYE DROPS | Pendopharm Division Of Pharmascience Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 11, 2021 | REBLOZYL | Celgene Inc | New Drug Submission (NDS) · Other |
| February 11, 2021 | VETMULIN 10% PREMIX | Huvepharma Eood | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 11, 2021 | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP | Omega Laboratories Limited | Abbreviated New Drug Submission (ANDS) · Other |
| February 10, 2021 | TOBRAMYCIN INJECTION USP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 10, 2021 | STIEVA-A | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 10, 2021 | SUBOXONE | Indivior Uk Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 10, 2021 | SONOVUE | Bracco Imaging Canada | Supplement to a New Drug Submission (SNDS) · Other |
| February 10, 2021 | TENOFOVIR | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 10, 2021 | METACAM FOR SWINE | Boehringer Ingelheim Animal Health Canada Inc. | New Drug Submission (NDS) · Admin |
| February 10, 2021 | SABRIL | Lundbeck Pharmaceuticals Llc | Supplement to a New Drug Submission (SNDS) · Other |
| February 10, 2021 | BELKYRA | Kythera Biopharmaceuticals Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 10, 2021 | ACH-SOLIFENACIN SUCCINATE | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 9, 2021 | RIVA-BACLOFEN | Laboratoire Riva Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| February 9, 2021 | PMSC-RIVAROXABAN | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| February 9, 2021 | DICLOFENAC-SR | Pro Doc Limitee | Supplement to a New Drug Submission (SNDS) · Admin |
| February 9, 2021 | TEVA-CAPTOPRIL | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 9, 2021 | SANDOZ CANDESARTAN PLUS | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 9, 2021 | PIPERACILLIN SODIUM/TAZOBACTAM SODIUM POWDER FOR INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 9, 2021 | SANDOZ CANDESARTAN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 8, 2021 | ULTOMIRIS | Alexion Pharma Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| February 8, 2021 | DEPO-MEDROL | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 8, 2021 | PRZ-TADALAFIL | Pharmaris Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| February 5, 2021 | XALKORI | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 5, 2021 | TEVA-HALOPERIDOL | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 5, 2021 | SANDOZ GLIMEPIRIDE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 5, 2021 | JAMP-ACET-TRAMADOL | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 5, 2021 | VITAMIN D3 ORAL SOLUTION | Galephar Pharmaceutical Research Inc | New Drug Submission (NDS) · Other |
| February 5, 2021 | BIKTARVY | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 5, 2021 | CLOBEX SPRAY | Galderma Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 5, 2021 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 5, 2021 | ONDISSOLVE ODF | Takeda Canada Incorporated | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 5, 2021 | AUBAGIO | Sanofi Genzyme, A Division Of Sanofi-Aventis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 5, 2021 | MINT-LOSARTAN/HCTZ; MINT-LOSARTAN/HCTZ DS | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 5, 2021 | TEVA-CLINDAMYCIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 5, 2021 | M-TADALAFIL | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 4, 2021 | CARBETOCIN INJECTION | Juno Pharmaceuticals Corp. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 4, 2021 | REACTINE ALLERGY | McNeil Consumer Healthcare, division of Johnson & Johnson Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 4, 2021 | TEVA-ZOPICLONE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 4, 2021 | VORICONAZOLE FOR INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 4, 2021 | IMMUNINE VH | Takeda Canada Incorporated | New Drug Submission (NDS) · Labelling Only |
| February 4, 2021 | COPAXONE | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 4, 2021 | AURO-ONDANSETRON INJECTION | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 4, 2021 | VONVENDI | Takeda Canada Incorporated | New Drug Submission (NDS) · Labelling Only |
| February 4, 2021 | ESOMEPRAZOLE | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| February 4, 2021 | TEVA-TRIAMTERENE/HCTZ | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 4, 2021 | CASPOFUNGIN FOR INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 4, 2021 | ALEVE CAPLETS | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 3, 2021 | PREGABALIN | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 3, 2021 | DEFINITY | Lantheus Mi Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 3, 2021 | NAT-ABIRATERONE | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 3, 2021 | PROFENDER | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| February 3, 2021 | M-ZOPICLONE | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 3, 2021 | NRA-HYDROXYCHLOROQUINE | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 3, 2021 | AURO-PRAMIPEXOLE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 3, 2021 | RAMIPRIL | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 3, 2021 | NINLARO | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| February 3, 2021 | M-NIFEDIPINE ER | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 3, 2021 | VFEND | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 3, 2021 | M-CETIRIZINE | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 3, 2021 | DONEPEZIL | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 2, 2021 | POMALYST | Celgene Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 2, 2021 | PROFENDER | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| February 2, 2021 | MYLERAN | Aspen Pharmacare Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 2, 2021 | PROFENDER | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| February 1, 2021 | TARO-TRAMADOL ER | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 1, 2021 | REDDY-ABIRATERONE | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 1, 2021 | AURO-MONTELUKAST | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| February 1, 2021 | LIBRELA | Zoetis Canada Inc | New Drug Submission (NDS) · Other |
| February 1, 2021 | SOLOFER | Pharmacosmos A | New Drug Submission (NDS) · Other |
| February 1, 2021 | REDDY-ABIRATERONE | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| February 1, 2021 | REDDY-ABIRATERONE | Dr Reddys Laboratories Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| January 29, 2021 | VIVOTIF | Emergent Biosolutions Berna Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| January 29, 2021 | APO-PROPRANOLOL | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 29, 2021 | CESAMET | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 29, 2021 | KYPROLIS | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 29, 2021 | DAPTOMYCIN FOR INJECTION | Juno Pharmaceuticals Corp. | Abbreviated New Drug Submission (ANDS) · Other |
| January 29, 2021 | TARO-BORTEZOMIB | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 29, 2021 | APO-POSACONAZOLE | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 28, 2021 | NASAL SPRAY ALLERGY 24HR | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 28, 2021 | 24HR NASAL ALLERGY RELIEF | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 28, 2021 | COLD + SINUS | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 28, 2021 | MONISTAT DERM CREAM | Insight Pharmaceuticals LLC | Supplement to a New Drug Submission (SNDS) · Other |
| January 28, 2021 | REMSIMA; REMSIMA SC | Celltrion Healthcare Co Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| January 28, 2021 | AG-LEVETIRACETAM | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 28, 2021 | VERAFLOX | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| January 28, 2021 | VERAFLOX | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| January 28, 2021 | VERAFLOX | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| January 28, 2021 | RIVASTIGMINE PATCH 10; RIVASTIGMINE PATCH 15; RIVASTIGMINE PATCH 5 | Strides Pharma Canada Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| January 28, 2021 | EZETIMIBE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 27, 2021 | TIVICAY | Viiv Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| January 27, 2021 | NAT-LEVETIRACETAM | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 27, 2021 | DUTASTERIDE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 27, 2021 | BUSCOPAN | Sanofi Consumer Health Inc | New Drug Submission (NDS) · Admin |
| January 27, 2021 | ROCALTROL | Searchlight Pharma Inc. | New Drug Submission (NDS) · Admin |
| January 27, 2021 | AG-NIFEDIPINE ER | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 27, 2021 | FLUNARIZINE | AA Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 27, 2021 | MAR-MYCOPHENOLIC ACID | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 27, 2021 | JAMP PIOGLITAZONE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| January 27, 2021 | NASACORT AQ | Sanofi Consumer Health Inc | New Drug Submission (NDS) · Admin |
| January 27, 2021 | OLMESARTAN | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 27, 2021 | LOSARTAN-HCTZ | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 27, 2021 | AG-CITALOPRAM | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 27, 2021 | XYLAC | Pendopharm Division Of Pharmascience Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 27, 2021 | ADDYI | Searchlight Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 26, 2021 | SYLVANT | Eusa Pharma (Uk) Limited | New Drug Submission (NDS) · Admin |
| January 26, 2021 | TAMSULOSIN CR | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 26, 2021 | DICLOFENAC EC | Sanis Health Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| January 26, 2021 | TEVA-QUETIAPINE XR | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 26, 2021 | APO-DILTIAZ CD | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 26, 2021 | VERAFLOX | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| January 26, 2021 | TRELSTAR | Knight Therapeutics Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 25, 2021 | ONDANSETRON INJECTION BP | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 25, 2021 | PRALUENT | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 25, 2021 | TEVA-5 ASA | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| January 25, 2021 | ACH-TELMISARTAN HCTZ | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 25, 2021 | APO-FLUVOXAMINE | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 25, 2021 | PMS-BUPRENORPHINE-NALOXONE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 25, 2021 | VINORELBINE INJECTION, USP | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 24, 2021 | JAMP NIFEDIPINE ER | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| January 22, 2021 | CHILDREN'S EUROPROFEN | Pendopharm Division Of Pharmascience Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 22, 2021 | OZEMPIC | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 22, 2021 | KESIMPTA | Novartis Pharmaceuticals Canada Inc. | New Drug Submission (NDS) · Other |
| January 22, 2021 | TEVA-PERINDOPRIL/INDAPAMIDE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 22, 2021 | VENCLEXTA | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| January 22, 2021 | ELETRIPTAN | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| January 22, 2021 | NEXGARD COMBO | Boehringer Ingelheim Animal Health Canada Inc. | New Drug Submission (NDS) · Other |
| January 22, 2021 | BIVALIRUDIN FOR INJECTION | Juno Pharmaceuticals Corp. | Abbreviated New Drug Submission (ANDS) · Other |
| January 21, 2021 | ZIAGEN | Viiv Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| January 21, 2021 | INFANRIX HEXA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 21, 2021 | BOOSTRIX-POLIO | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 21, 2021 | BOOSTRIX | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 21, 2021 | JAMP ABIRATERONE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 21, 2021 | ONCASPAR | Servier Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 21, 2021 | LOVENOX | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 21, 2021 | ELAPRASE | Shire Human Genetic Therapies Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 21, 2021 | JAMP ABIRATERONE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| January 21, 2021 | TEVA-VORICONAZOLE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 21, 2021 | ROMPUN | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| January 21, 2021 | ROMPUN | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| January 21, 2021 | ADALAT XL | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 20, 2021 | TEVA-DICLOFENAC-K | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| January 20, 2021 | DUPIXENT | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 20, 2021 | IMIPENEM AND CILASTATIN FOR INJECTION USP | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 20, 2021 | BASAGLAR | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 20, 2021 | COSENTYX | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 20, 2021 | ERTAPENEM FOR INJECTION | Dr Reddys Laboratories Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| January 20, 2021 | TEVA-CILAZAPRIL/HCTZ | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 20, 2021 | BIO-RAMIPRIL | Biomed Pharma | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| January 20, 2021 | AURO-ONDANSETRON ODT | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 19, 2021 | TRANDOLAPRIL | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 19, 2021 | IDARUBICIN | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Admin |
| January 19, 2021 | AG-HYDROXYCHLOROQUINE | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 19, 2021 | JAMP KETOROLAC | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| January 19, 2021 | AG-ESCITALOPRAM TABLETS | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 19, 2021 | DRONTAL | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| January 19, 2021 | FLUOXETINE | Apotex Inc. | New Drug Submission (NDS) · Labelling Only |
| January 19, 2021 | TARO-IMIPENEM-CILASTATIN | Sun Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| January 19, 2021 | ZOLADEX LA | Tersera Therapeutics Llc | Supplement to a New Drug Submission (SNDS) · Other |
| January 19, 2021 | CEFTIOCYL | Vetoquinol N A Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 19, 2021 | SINEMET | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 18, 2021 | PMS-OMEPRAZOLE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 18, 2021 | TERAZOSIN | Apotex Inc. | New Drug Submission (NDS) · Labelling Only |
| January 18, 2021 | FLUCONAZOLE INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 18, 2021 | TAGRISSO | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Priority |
| January 17, 2021 | PMS-ONDANSETRON | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 17, 2021 | JAMP-CELECOXIB | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 17, 2021 | APO-ONDANSETRON | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 15, 2021 | ADYNOVATE | Shire Pharma Canada Ulc | New Drug Submission (NDS) · Labelling Only |
| January 15, 2021 | TISSUEBLUE | Dutch Ophthalmic Research Center International Bv | New Drug Submission (NDS) · New Active Substance (NAS) |
| January 15, 2021 | SANDOZ ABIRATERONE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| January 15, 2021 | SANDOZ ABIRATERONE | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 15, 2021 | MAR-PALIPERIDONE | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 15, 2021 | SANDOZ ABIRATERONE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 15, 2021 | FLUCONAZOLE INJECTION SDZ | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 15, 2021 | APTIVUS | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| January 15, 2021 | MICARDIS PLUS | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| January 15, 2021 | APO-FLUTICASONE HFA | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 14, 2021 | EXTAVIA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 14, 2021 | ADALIMUMAB INJECTION | Pfizer Canada Ulc | New Drug Submission (NDS) · Other |
| January 14, 2021 | SUPEMTEK | Sanofi Pasteur Limited | New Drug Submission (NDS) · New Active Substance (NAS) |
| January 14, 2021 | DRONCIT INJECTABLE | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| January 14, 2021 | DRONCIT FELINE TABLETS | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| January 14, 2021 | DRONCIT CANINE TABLETS | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| January 14, 2021 | KYLEENA | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 14, 2021 | ENTOCORT ENEMA | Tillotts Pharma Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| January 14, 2021 | APO-METOPROLOL; APO-METOPROLOL (TYPE L); APO-METOPROLOL SR | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 14, 2021 | OMNIPAQUE 240; OMNIPAQUE 300; OMNIPAQUE 350; OMNIPAQUE 180 | Ge Healthcare Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 13, 2021 | DEXMEDETOMIDINE HYDROCHORIDE FOR INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 13, 2021 | TECENTRIQ | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| January 13, 2021 | SANDOZ MIGLUSTAT | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 13, 2021 | BAVENCIO | Emd Serono A Division Of Emd Inc Canada | Supplement to a New Drug Submission (SNDS) · Other |
| January 13, 2021 | MAR-ABIRATERONE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 13, 2021 | JAMP-ASA 81 MG EC | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 13, 2021 | MOTRIN 200 MG; MOTRIN 300 MG; MOTRIN 400 MG | McNeil Consumer Healthcare, division of Johnson & Johnson Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 13, 2021 | MOTRIN PLATINUM MUSCLE AND BODY | McNeil Consumer Healthcare, division of Johnson & Johnson Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 13, 2021 | ASA 81 MG | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 13, 2021 | MAR-ABIRATERONE | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 13, 2021 | APO-SILODOSIN | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 12, 2021 | XARELTO | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 11, 2021 | VYEPTI | Lundbeck Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| January 11, 2021 | APO-ABIRATERONE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 11, 2021 | APO-ABIRATERONE FILM COATED TABLETS | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 11, 2021 | NAT-ABIRATERONE | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 11, 2021 | APO-ABIRATERONE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 11, 2021 | PAROXETINE | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| January 11, 2021 | APO-ABIRATERONE FILM COATED TABLETS | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 11, 2021 | BUSULFAN FOR INJECTION | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 11, 2021 | AURO-CEFUROXIME | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| January 11, 2021 | AIVLOSIN WATER SOLUBLE GRANULES | Eco Animal Health Limited | Supplement to a New Drug Submission (SNDS) · Other |
| January 11, 2021 | ALTACE | Bausch Health, Canada Inc. | New Drug Submission (NDS) · Labelling Only |
| January 11, 2021 | NAT-ABIRATERONE | Natco Pharma (Canada) Inc | Abbreviated New Drug Submission (ANDS) · Other |
| January 11, 2021 | PMS-METOCLOPRAMIDE HYDROCHLORIDE INJECTION | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 11, 2021 | APO-ABIRATERONE; APO-ABIRATERONE FILM COATED TABLETS | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 11, 2021 | APO-ABIRATERONE | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 8, 2021 | BENLYSTA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 8, 2021 | PMS-ABIRATERONE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 8, 2021 | PMS-ABIRATERONE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 8, 2021 | IPG-ZOPICLONE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 8, 2021 | NEUPOGEN | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 8, 2021 | NEULASTA | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 8, 2021 | DICLECTIN | Duchesnay Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 8, 2021 | RETIN-A | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 8, 2021 | PMS-ABIRATERONE | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 8, 2021 | PMS-ABIRATERONE | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 8, 2021 | ROZLYTREK | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| January 7, 2021 | RABAVERT | Bavarian Nordic As | New Drug Submission (NDS) · Admin |
| January 7, 2021 | FOCLIVIA | Seqirus Uk Limited | New Drug Submission (NDS) · Other |
| January 7, 2021 | DRONCIT | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| January 7, 2021 | IPG-CELECOXIB | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 7, 2021 | ASERVO EQUIHALER | Boehringer Ingelheim Animal Health Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 7, 2021 | MAR-ZOPICLONE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 7, 2021 | PHARMA-AMLODIPINE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 7, 2021 | AG-PAROXETINE TABLETS | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 7, 2021 | AG-OSELTAMIVIR | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 7, 2021 | AG-AMOXI CLAV | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 7, 2021 | ZYTIGA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 7, 2021 | KALETRA | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| January 7, 2021 | SANDOZ SILODOSIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 7, 2021 | SANDOZ SILODOSIN | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 6, 2021 | ONDANSETRON INJECTION, USP | Baxter Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 6, 2021 | MINT-ONDANSETRON ODT | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 6, 2021 | BAYTRIL | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| January 6, 2021 | NRA-QUETIAPINE XR | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 6, 2021 | BAYTRIL | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| January 6, 2021 | FOSRENOL | Takeda Canada Incorporated | New Drug Submission (NDS) · Labelling Only |
| January 6, 2021 | ORAP | AA Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 5, 2021 | FENOFIBRATE | AA Pharma Inc. | New Drug Submission (NDS) · Admin |
| January 5, 2021 | DRONTAL PLUS | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| January 5, 2021 | DRONTAL PLUS | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| January 5, 2021 | METACAM ORAL SUSPENSION | Boehringer Ingelheim Animal Health Canada Inc. | New Drug Submission (NDS) · Admin |
| January 5, 2021 | DRONCIT 9% ORAL PASTE FOR HORSES | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| January 5, 2021 | ZIRABEV | Pfizer Canada Ulc | New Drug Submission (NDS) · Other |
| January 5, 2021 | APO-DESVENLAFAXINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 5, 2021 | VERAPAMIL HYDROCHLORIDE INJECTION USP | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Labelling Only |
| January 5, 2021 | ONUREG | Celgene Inc | New Drug Submission (NDS) · Priority |
| January 5, 2021 | FYCOMPA | Eisai Limited | Supplement to a New Drug Submission (SNDS) · Other |
| January 5, 2021 | MVASI | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 4, 2021 | TARO-CEFPROZIL | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 4, 2021 | APO-PERINDOPRIL-INDAPAMIDE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 4, 2021 | ACTEMRA IV; ACTEMRA SC | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| January 4, 2021 | TARO-DILTIAZEM T | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 4, 2021 | TEVA-MONTELUKAST | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 4, 2021 | APO-CILAZAPRIL/HCTZ | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 4, 2021 | PMS-EMTRICITABINE-TENOFOVIR | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 4, 2021 | APO-INDAPAMIDE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 4, 2021 | AURO-MONTELUKAST CHEWABLE TABLET | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 4, 2021 | APO-TRIFLURIDINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 4, 2021 | ACCEL-ONDANSETRON | Accel Pharma Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 4, 2021 | METOPROLOL TARTRATE INJECTION USP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 4, 2021 | MAR-DILTIAZEM T | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 1, 2021 | QVAR | Bausch Health, Canada Inc. | New Drug Submission (NDS) · Labelling Only |